Introduction {#s1}
============

In biological systems, concentrations of extracellular signaling molecules, such as hormones and growth factors, often vary by orders of magnitude. Therefore, the ability to sense relative rather than absolute signals, that is detect fold changes in extracellular cues, is critical for making accurate decisions in different biological contexts ([@bib5]). Relative sensing requires both the ability to store memories of past environmental stimuli and the capacity to quickly and efficiently compute relative signals ([@bib2]).

Relative sensing of environmental inputs has been previosuly investigated in bacteria, with the *E. coli* chemotaxis being a classic example ([@bib39]; [@bib6]; [@bib4]; [@bib47]). Studies have also explored relative sensing in a variety of eukaryotic systems. When responding to constant stimuli, experiments with the signaling proteins ERK ([@bib12]) and β-catenin ([@bib21]) showed that fold changes in their nuclear activity were robust to cell-to-cell variability ([@bib12]) and variability in signaling network parameters ([@bib21]). These observations suggested that gene expression of target genes may respond, at the single cell level, to fold changes rather than absolute activities of these proteins. Later studies of the NF-κB ([@bib35]) and TGF-β/SMAD pathways ([@bib18]) also showed that genes directly controlled by these proteins often respond to their fold changes at the single cell level. Recent work has explored relative sensing at the organism level in plants, where the chlorophyll activity was found to be proportional to the fold change in external light intensity ([@bib50]).

Despite the insights gained in the aforementioned studies, the molecular mechanisms allowing cells to detect fold changes in extracellular stimuli are not well understood. The key unresolved questions are: (1) where and how the memories of background extracellular stimuli are stored within the cell, (2) what makes these memories specific to particular stimuli, and (3) how the cells subsequently use the stored memories to compute fold changes.

In this work, using the growth factor-activated PI3K/Akt signaling pathway, we describe a novel non-transcriptional mechanism of relative sensing in mammalian cells. The mechanism operates on fast timescales of dozens minutes to hours, and across more than an order of magnitude of extracellular background stimuli. We derive key aggregate parameters of the signaling cascade that determine the accuracy and the background range of relative sensing. We also experimentally validate the accuracy of relative sensing by stimulating cells with multiple fold changes of two physiologically important ligands, EGF and HGF. Furthermore, we demonstrate that ligand relative sensing is reliably propagated to an important downstream target of the PI3K/Akt pathway.

Results {#s2}
=======

Stimulation of mammalian cells with growth factors elicits a variety of context-dependent, phenotypic responses, including cell migration, proliferation, and cell survival ([@bib9]). Akt serves as a central hub of multiple growth factor-activated signaling cascades ([@bib26]). Naturally, Akt phosphorylation-dependent (pAkt) pathways are implicated in multiple human diseases, such as many types of cancers ([@bib15]; [@bib26]), diabetes ([@bib54]), and psychiatric disorders ([@bib20]; [@bib38]).

To understand how the immediate-early dynamics of the Akt pathway depend on the background level of growth factors, we used immunofluorescence to quantify the levels of pAkt in epidermal growth factor (EGF)- stimulated human non-transformed mammary epithelial MCF10A cells (Materials and methods, [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). Within minutes of continuous stimulation with EGF pAkt reached maximum response, and then decayed to low steady state levels within hours ([Figure 1a](#fig1){ref-type="fig"}). The resulting steady state pAkt levels were approximately independent of the EGF stimulus, indicating an approximately adaptive response ([@bib19]; [@bib47]; [Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}). In the sensitive range of EGF concentrations, maximal pAkt response was approximately proportional to the logarithm of the EGF stimulus ([Figure 1b](#fig1){ref-type="fig"}). Quantitative western blot experiments demonstrated that in this logarithmic regime, pAkt levels were approximately linearly proportional to the phosphorylation level of EGF receptors (EGFRs) ([Figure 1---figure supplement 3](#fig1s3){ref-type="fig"}). The logarithmic dependence of EGFR phosphorylation levels on EGF stimulation has been previously attributed to a mixture of receptor species with varying affinities to the ligand, negative cooperativity of ligand binding to receptor dimers, and oligomeric aggregation of receptors ([@bib31]; [@bib10]; [@bib57]; [@bib36]; [@bib28]).

![EGF-induced Akt phosphorylation and desensitization in MCF10A cells.\
(**a**) Temporal profiles of phosphorylated Akt (pAkt) in cells exposed to increasing stimulation with extracellular EGF (see inset). (**b**) Maximal pAkt response as a function of EGF stimulation. (**c**) Steady state levels of surface EGFR (sEGFR) after 150 and 180 min of stimulation with a constant level of EGF. (**d**) Desensitization of the maximal pAkt response to an abrupt EGF stimulation. MCF10A cells were pre-treated with increasing background doses of EGF (x-axis) for three hours, followed by a second abrupt stimulation with the same concentration of EGF (2 ng/ml); the inset shows a schematic illustration of the experimental protocol. In all subpanels, error bars represent the standard deviation of n = 3 technical replicates. Source data: pakt_timecourses_first_step.mat and segfr_150_180mins.doseresponse.mat (available in [Source code 1](#scode1){ref-type="supplementary-material"}).](elife-50342-fig1){#fig1}

Continuous stimulation with EGF resulted in the abundance of cell-surface EGF receptors (sEGFR) also decreasing proportionally to the logarithm of the background EGF level, and reaching a new steady state within hours ([Figure 1c](#fig1){ref-type="fig"}). Notably, prior exposure with EGF desensitized cells to subsequent EGF stimulations in a quantitative manner. When we first pre-exposed cells to different levels of EGF for 3 hr and then stimulated them with the same final EGF concentration (2 ng/ml)), the maximal pAkt response decreased monotonically with increasing pre-exposure EGF levels ([Figure 1d](#fig1){ref-type="fig"}). These experiments demonstrate that the pAkt response to an abrupt EGF stimulation is strongly affected by background EGF levels, and that this effect is likely mediated by the endocytosis-based removal of activated EGFRs from the cell surface ([@bib55]).

Using pharmacological perturbations of the EGFR/Akt pathway, we confirmed that the desensitization of the phosphorylation response ([Figure 1d](#fig1){ref-type="fig"}) was likely due to receptor-based mechanisms upstream of Akt activation, and did not depend on its downregulation, for example, through phosphorylation-dependent Akt degradation ([@bib59]). Specifically, we used SC79, a small molecule which promotes Akt phosphorylation even in the absence of extracellular ligands ([@bib30]). Unlike the desensitization observed in the growth factor-induced pAkt response ([Figure 1d](#fig1){ref-type="fig"}), the pAkt response following stimulation with SC79 did not depend on the background EGF pre-exposure ([Figure 1---figure supplement 4](#fig1s4){ref-type="fig"}). This result supports the conclusion that the EGF desensitization mechanism was upstream of Akt.

To understand how background EGF levels affect the pAkt response to subsequent EGF stimulation we next constructed an ordinary differential equation (ODE) model of EGF-dependent Akt phosphorylation. The model included several well-established features of the EGFR signaling cascade ([@bib11]), such as endocytosis and degradation of activated receptors (Materials and methods) ([Figure 2a](#fig2){ref-type="fig"}). We constrained the ranges of model parameters based on literature-derived estimates ([Supplementary file 1a](#supp1){ref-type="supplementary-material"}), and fitted the model using experimental data on pAkt time courses ([Figure 1a](#fig1){ref-type="fig"}) and steady state sEGFR levels ([Figure 1c](#fig1){ref-type="fig"}) at different doses of EGF stimulations. We then used simulated annealing to optimize model parameters (Materials and methods, [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}), and considered multiple distinct parameter sets from the optimization runs for further computational analysis.

![Computational model demonstrates the ability of the system to sense relative changes of EGF levels.\
(**a**) Schematic of the computational model of the EGFR signaling cascade leading to phosphorylation of Akt. Rate constants marked with asterisks correspond to reactions associated with activated (phosphorylated) receptors. Only a subset of reactions in the network are shown for brevity. (**b**) In silico *p*rotocol used to explore relative sensing, showing the temporal profiles of EGF stimulation (top) and the corresponding profiles pAkt response (bottom). Cells were first exposed to various background EGF stimulations (blue and red) and were next subjected to the same abrupt fold change in EGF at time *t~0~*. The resulting maximal pAkt responses were similar for the same EGF fold change independent of background EGF stimulation, indicating relative sensing. (**c**) The maximal pAkt response observed after exposing the ODE model in silico to different background EGF levels (x axis), followed by a 2-, 3-, 4-, or 6- fold increase (different colors) in EGF; inset shows pAkt response over a wider range of background EGF levels. (**d**) Maximal pAkt responses (y axis) induced by stimulation with different EGF background levels (data points with the same shape and color) were combined and plotted as a function of the EGF fold change (x axis). Dashed line represents log-linear fit to data (Pearson's *r^2^* = 0.96, regression *p* value \< 10^−15^). In all subpanels, error bars represent the standard deviation of n = 10 model fits. Source code: [https://github.com/dixitpd/FoldChange/](https://github.com/dixitpd/FoldChange/tree/master/Code).](elife-50342-fig2){#fig2}

Using the fitted dynamical model ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}), we explored the ability of the Akt pathway to respond to relative, rather than absolute, changes in EGF levels. To that end, we simulated the pAkt response by exposing the model *in silico* to a range of background EGF levels followed by different abrupt fold change increases in EGF concentration ([Figure 2b](#fig2){ref-type="fig"}). The model predicted that the maximal pAkt response indeed depends primarily on the EGF fold change relative to the background stimulation levels ([Figure 2c](#fig2){ref-type="fig"}). This relative sensing of EGF stimuli occurred over an order of magnitude of background EGF concentrations, and the resulting pAkt response was approximately proportional to the logarithm of the EGF fold change ([Figure 2d](#fig2){ref-type="fig"}). Notably, the model predicted relative sensing exactly in the range of EGF background concentrations where sEGFR endocytosis was sensitive to background ligand stimulation. At low EGF background concentrations (\<0.01 ng/ml), no substantial sEGFR removal was predicted at the steady state ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}), and consequently there was no significant desensitization of the pAkt response. In that regime, the pAkt response to an abrupt fold change depended primarily on the absolute EGF level. In contrast, at high background EGF concentrations (\>1 ng/ml), a large fraction of sEGFR was already removed from cell surface and consequently the network responded only weakly to further EGF stimulation.

Next, we experimentally tested the model-predicted relative sensing in MCF10A cells. Cells were first treated with various background EGF concentrations for three hours to ensure that sEGFR reached steady state levels ([Figure 1c](#fig1){ref-type="fig"}), and that pAkt had decayed after a transient increase ([Figure 1a](#fig1){ref-type="fig"}). As in the computational analysis ([Figure 2b](#fig2){ref-type="fig"}), cells were then exposed to different fold changes in EGF levels; pAkt levels were measured at 2.5, 5, 10, 15, 30 and 45 min after the step increase in EGF stimulation ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). Similar results were observed in two independent biological replicates ([Figure 3---figure supplements 1](#fig3s1){ref-type="fig"}, [2](#fig3s2){ref-type="fig"} and [3](#fig3s3){ref-type="fig"}), and the experiments confirmed the predictions of the computational model that maximal pAkt response depends primarily on the fold change of EGF and not its absolute concentration ([Figure 3a](#fig3){ref-type="fig"}, [Figure 3---figure supplement 4](#fig3s4){ref-type="fig"}). Specifically, across more than an order of magnitude of EGF background concentrations (0.03--0.5 ng/ml) the same EGF fold change (lines with the same colors in [Figure 3a](#fig3){ref-type="fig"}) elicited similar pAkt responses. The concentration range in which we obsered relative sensing was consistent with recent estimations of in vivo EGF levels ([@bib44]). In close agreement with the computational model predictions, the maximal pAkt response was approximately proportional to the logarithm of EGF fold change ([Figure 3b](#fig3){ref-type="fig"}). Interestingly, in addition to the maximal pAkt response, approximate relative sensing was also observed for the time integral of pAkt levels ([Figure 3---figure supplement 5](#fig3s5){ref-type="fig"}), and for the entire time course of pAkt dynamics ([Figure 3---figure supplement 6](#fig3s6){ref-type="fig"}).

![Experimental validation of EGF relative sensing by pAkt in MCF10A cells.\
(**a**) The maximal pAkt responses after exposing cells to different background EGF levels (x axis) for 3 hr, followed by 2-, 3-, 4-, and 6-fold increases (different colors) in EGF. Inset shows experimental pAkt response over a wider range of background EGF levels. (**b**) Maximal pAkt responses (y axis) to fold changes in EGF depended approximately logarithmically on the fold change. Maximal pAkt responses induced by stimulation with various EGF background levels (data points with the same shape and color) were combined and plotted as a function of the EGF fold change (x axis). Dashed line represents log-linear fit to the data (Pearson's *r^2^* = 0.93, regression *p* value \< 10^−11^). In all subpanels, error bars represent the standard deviation of n = 3 technical replicates. Source data: expt_data.mat (available in [Source code 1](#scode1){ref-type="supplementary-material"}).](elife-50342-fig3){#fig3}

To better understand the mechanism responsible for the observed relative sensing of extracellular EGF concentration, we next constructed a simplified analytical model of the signaling network (see Appendix). This model revealed that, across a broad range of background concentrations, the steady-state abundance of cell surface receptors $\left\lbrack R \right\rbrack_{T}$ decreases approximately log-linearly as a function of the background ligand (EGF) concentration $\left\lbrack L \right\rbrack_{0}$ ([Equation 1](#equ1){ref-type="disp-formula"} and [Figure 4a](#fig4){ref-type="fig"}):$$\left. \left\lbrack R \right\rbrack_{T} \right.\sim constant - a*{\log\left\lbrack L \right\rbrack}_{0}$$and that the maximal receptor phosphorylation response $\left\lbrack {LR_{2}^{*}} \right\rbrack_{max}$ depends approximately log-linearly on the level of the subsequent stimulation $\left\lbrack L \right\rbrack_{1}$ and linearly on the steady-state receptor abundance $\left\lbrack R \right\rbrack_{T}$ ([Equation 2](#equ2){ref-type="disp-formula"}, [Figure 4b](#fig4){ref-type="fig"}):$$\left. \left\lbrack {LR_{2}^{*}} \right\rbrack_{max} \right.\sim b*\left( {\log{\left\lbrack L \right\rbrack_{1} + \frac{\left\lbrack R \right\rbrack_{T}}{a}}} \right) + constant$$where *a* and *b* are numerical constants (Appendix). As a result of these relationships, the phosphorylation response $\left\lbrack {LR_{2}^{*}} \right\rbrack_{max}$ after an increase of ligand concentration from $\left\lbrack L \right\rbrack_{0}$ to $\left\lbrack L \right\rbrack_{1}$ depends, in agreement with computational and experimental analyses, approximately on the logarithm of the stimulation fold change $\frac{\left\lbrack L \right\rbrack_{1}}{\left\lbrack L \right\rbrack_{0}}$:$$\lbrack LR_{2}^{\ast}\rbrack_{max} \sim b \times \left( {\log\lbrack L\rbrack_{1} + \frac{\lbrack R\rbrack_{T}}{a}} \right) \sim b \times \left( {\log\lbrack L\rbrack_{1} - \log\lbrack L\rbrack_{0}} \right) \sim b\log\frac{\lbrack L\rbrack_{1}}{\lbrack L\rbrack_{0}}$$

![Analytical model of the system predicts log-linear relationships leading to receptor-based memory and relative sensing.\
(**a**) Approximate log-linear dependence of the scaled steady-state surface receptor abundance $\lbrack R\rbrack_{T}$ on the normalized background ligand concentration $u_{0} = \lbrack L\rbrack_{0}/K_{d1}$, where $K_{d1}$ is the equilibrium dissociation constant of EGF binding to EGFR. (**b**) Approximate log-linear dependence of the maximal phosphorylation response on the normalized ligand stimulus $u_{1} = \lbrack L\rbrack_{1}/K_{d1}$. Dashed red lines represent the exact log-linear approximation.](elife-50342-fig4){#fig4}

The analytical model (Appendix) also revealed that the range of the background ligand concentrations where relative sensing is observed is primarily determined by two aggregate systems parameters, which we denote $\alpha$ and $\beta$ ([Equations 4 and 5](#equ4 equ5){ref-type="disp-formula"}). The parameter $\alpha$ quantifies the ability of the signaling network to capture the input signal (EGF) and elicit a downstream phosphorylation response. The parameter $\beta$ quantifies the ability of the network to preferentially internalize and degrade active (phosphorylated) receptors relative to inactive (non-phosphorylated) receptors. The two aggregate parameters are expressed as follows:$$\alpha = \frac{k_{p} + k_{dp}}{k_{dp}} \times \frac{k_{2}}{k_{- 2}} \times R_{0}$$where $k_{p}$ is the rate of receptor phosphorylation and $k_{dp}$ is the rate of receptor de-phosphorylation, $k_{2}$ is the rate of receptor dimerization, $k_{- 2}$ is the dissociation rate of receptor dimers, and $R_{0}$ is the total number of cell-surface receptors at the steady state in the absence of extracellular stimuli and$$\beta = \frac{k_{p}}{k_{dp} + k_{p}} \times \frac{k_{i}^{*}}{k_{i}} \times \frac{\frac{k_{deg}^{*}}{k_{deg}^{*} + k_{rec}^{*}}}{\frac{k_{deg}}{k_{deg + k_{rec}}}}$$where $k_{i}^{*},{k}_{rec}^{*},{k}_{deg}^{*}$ and $k_{i}{,k}_{rec},{k}_{deg}$ are correspondingly the rates of internalization, recycling, and degradation of the active (phosphorylated) and non-active receptors. Notably, an increase in the value of α increases signal sensitivity and receptor dimerization and phosphorylation. This shifts the relative sensing range to lower ligand concentrations ([Figure 5a](#fig5){ref-type="fig"}). In turn, an increase in the value of *β* increases the fraction of active receptors being internalized and degraded. This increases the range of background ligand concentrations where the relative sensing is observed ([Figure 5b](#fig5){ref-type="fig"}). Based on the best-fit ODE model parameter sets, we estimate *α* \~ 15 and *β* \~ 40 (Appendix). As an example, in [Figure 5](#fig5){ref-type="fig"} we show the scaled phosphorylation response to a six-fold change in EGF concentration as a function of the scaled background ligand concentration u~0~ for different values of α ([Figure 5a](#fig5){ref-type="fig"}) and β ([Figure 5b](#fig5){ref-type="fig"}); the green arrows in the figure represent the predicted range of fold change detection. The model analysis showed that the relative sensing occurs across over an order of magnitude of background ligand concentrations (Appendix). Furthermore, the analytical model revealed that relative sensing does not require receptor dimerization, and similar sensing mechanisms can operate in pathways where signaling is initiated by monomeric receptors (Appendix).

![Analytical model predicts the range of approximate EGF relative sensing.\
Scaled phosphorylation response to a six-fold change in extracellular EGF concentration as a function of the scaled background ligand concentration ($u_{0} = {\lbrack L\rbrack_{0}}/K_{d1}$ ). (**a**) The phosphorylation response as a function of background ligand concentration (x-axis) is shown for different values of the parameter α (y-axis), when the parameter β is fixed at β=40. (**b**) The phosphorylation response as a function of background ligand concentration (x-axis) is shown for different values of β (y-axis), when α is fixed at α=15. The colors represent the scaled phosphorylation response. The green dashed lines delineate the parameter ranges where the fold change detection is \>90% accurate. The horizontal black lines correspond to the parameter values α=15 and β=40, which were estimated from experimental data fits; the horizontal green double arrows represent the predicted range of relative sensing for the investigated PI3K-Akt cascade.](elife-50342-fig5){#fig5}

In addition to EGF, Akt phosphorylation can be induced by multiple other ligands, including hepatocyte growth factor (HGF) ([@bib49]) which binds to its cognate receptor cMet ([@bib51]). Similar to EGFRs, upon ligand binding, cMet receptors dimerize ([@bib34]) and cross-phosphorylate each other; this leads to phosphorylation of multiple downstream targets, including Akt. To investigate the specificity of the receptor-based cell memory to past ligand exposures, we used the two ligands, EGF and HGF, which share many signaling components downstream of their cognate receptors ([@bib60]). We exposed cells to background doses of either HGF or EGF for three hours, and then stimulated cells using either the same or the other growth factor to elicit pAkt response ([Figure 6a,b](#fig6){ref-type="fig"}). Pre-exposure with HGF did not substantially downregulate EGF-induced pAkt responses, but substantially decreased HGF-induced responses ([Figure 6a](#fig6){ref-type="fig"}). Similarly, we observed a relatively small desensitization of HGF-induced responses due to pre-exposure with EGF, while there was a significant desensitization of EGF-induced pAkt responses ([Figure 6b](#fig6){ref-type="fig"}). We further confirmed that exposure of MCF10A cells to various concentrations of HGF leads to pronounced HGF-dependent removal of cMet from the cell surface, without significant removal of sEGFR ([Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}). Similarly, the pre-exposure of cells to EGF leads to EGF-dependent removal of sEGFR without a significant change in surface cMet abundance ([Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}). These observations support the mechanism in which the relative sensing of extracellular ligands relies on the memory of their past exposures effectively encoded in the abundances of their cognate cell-surface receptors.

![Desensitization and ligand-specific cell memory for EGF- and HGF-induced pAkt responses.\
MCF10A cells were first exposed to various background concentrations of either HGF or EGF for three hours, and then abruptly stimulated using either the same or the other growth factor. pAkt levels were then measured 10 min after the addition of the second stimulus. (**a**) EGF- (blue, 2.5 ng/ml) or HGF- (red, 4 ng/ml) induced pAkt response in cells pre-exposed with various background concentrations of HGF (x axis). (**b**) EGF- (blue, 2.5 ng/ml) or HGF- (red, 4 ng/ml) induced pAkt response in cells pre-exposed with various background concentrations of EGF (x axis). (**c**) The maximal pAkt response in MCF10A cells exposed to different background doses of HGF (x axis) for 3 hr, followed by 2-, 4-, and 8-fold increase (different colors) of HGF. Inset shows experimental pAkt response over a wider range of background HGF levels. (**d**) The maximal pAkt responses (y axis) to HGF fold changes depended approximately logarithmically on the fold change (x axis). Maximal pAkt responses induced by stimulation with various HGF background levels (data points with the same shape and color) were combined and plotted as a function of the HGF fold change (x axis). Dashed line represents log-linear fit to data (Pearson's *r^2^* = 0.88, regression *p* value \< 10^−6^). In all subpanels, error bars represent the standard deviation of n = 3 technical replicates. Source data: expt_data.mat (available in [Source code 1](#scode1){ref-type="supplementary-material"}).](elife-50342-fig6){#fig6}

Given the observed HGF-dependent removal of cell surface cMet receptors and the resulting pAkt desensitization, we investigated next whether the maximal pAkt response depends, similarly to EGF, on the relative fold changes in the level of extracellular HGF. To that end, we exposed cells to a range of different background levels of HGF, and then stimulated cells with different fold changes in HGF concentrations ([Figure 6c,d](#fig6){ref-type="fig"} and [Figure 6---figure supplement 2](#fig6s2){ref-type="fig"}). These experiments demonstrated that HGF-induced phosphorylation of Akt also depends primarily on the fold change in extracellular HGF concentration across almost an order of magnitude of background HGF exposures (between 0.1 and 1 ng/ml HGF) ([Figure 6c](#fig6){ref-type="fig"}). Moreover, like EGF, the maximum pAkt levels depended approximately log-linearly on the HGF fold change ([Figure 6d](#fig6){ref-type="fig"}).

Relative sensing of extracellular ligands should affect important downstream biological targets of the PI3K-Akt pathway. The FoxO3 transcription factor is a key effector of the pathway, and it is involved in diverse cellular processes including apoptosis, proliferation, and metabolism ([@bib53]). Akt phosphorylation of FoxO3 leads to its translocation from the nucleus to cytoplasm and subsequent transcriptional deactivation ([@bib53]). Notably, following Akt activation, the typical nuclear translocation timescale for FoxO family proteins is short (less than 5 min) ([@bib22]). To investigate FoxO3 activation induced by EGF stimulation, we used quantitative immunofluorescence to measure its nuclear-to-cytoplasm ratio ([@bib58]). We exposed cells to two different background EGF levels for three hours, and then treated them with two different abrupt fold changes in EGF concentrations. Consistent with relative sensing by pAkt, the nuclear-to-cytoplasmic ratio of FoxO3 also reflected the relative, rather than the absolute changes in EGF stimulation ([Figure 7](#fig7){ref-type="fig"} and [Figure 7---figure supplement 1](#fig7s1){ref-type="fig"}). Thus, relative sensing of the growth factor signal is faithfully transmitted in MCF10A cells to at least some of the physiologically important effectors of the PI3K-Akt pathway.

![Relative sensing of EGF concentrations by pAkt is propagated to FoxO3.\
MCF10A cells were first exposed to two background concentrations of EGF for three hours, and then were stimulated with 3- and 6- fold increase in EGF concentrations. The ratio of nuclear-to-cytoplasmic FoxO3 levels (y-axis) was measured using quantitative immunofluorescence (Materials and methods) after 15 min of the EGF fold changes. Statistical significance was calculated using the Wilcoxon rank sum test (n = 5); \* corresponds to p\<0.01, and n. s. corresponds to p\>0.1. Error bars represent the standard deviation of n = 5 technical replicates. Source data: expt_data.mat (available in [Source code 1](#scode1){ref-type="supplementary-material"}).](elife-50342-fig7){#fig7}

Discussion {#s3}
==========

Receptor endocytosis and down-regulation, following ligand stimulation, has been canonically associated with signal and circuit desensitization ([@bib19]; [@bib48]; [@bib17]). Our study suggests an additional and more quantitative role of receptors endocytosis in mammalian cells. Specifically, receptor endocytosis may allow cells to continuously monitor signals in their environment ([@bib7]; [@bib8]; [@bib40]) by dynamically adjusting the number of ligand-cognate receptors on the cell surface. Our analysis also demonstrates that the memory of past stimuli, effectively encoded in the number of surface receptors, may be signal-specific, at least for some ligands, due to the selective removal of ligand-cognate receptors. The combination of logarithmic pAkt response, and the logarithmic dependence of the ligand-specific memory on the background signal, allows cells to respond to relative changes in environmental stimuli. We note that the described relative sensing mechanism is not a direct consequence of either simple adaptation to various levels of background signals or logarithmic activation response ([@bib47]; [@bib1]; [@bib2]).

Previous studies ([@bib12]; [@bib21]; [@bib35]) have demonstrated that transcriptional motifs may efficiently buffer cell-to-cell variability in signaling components when responding to a constant extracellular stimulation. In contrast, our study describes a non-transcriptional mechanism of sensing extracellular signal changes relative to past extracellular stimulation. Although the pAkt response to an abrupt stimulation is relatively fast (\~5--15 min, [Figure 1a](#fig1){ref-type="fig"}), and therefore non-transcriptional in nature, the sustained production and delivery of cell surface receptors is essential to establishing the signal-dependent and receptor-mediated memory. Therefore, sustained transcription and translation of network comonents are necessary for proper functioning of the described sensing mechanism.

Although there are usually \~10^5^--10^6^ EGFR receptors on mammalian cell surface ([@bib46]), the downstream network response, for example Akt phosphorylation, often saturates when only a relatively small fraction (5--10%) of the receptors are bound to their cognate ligands ([@bib11]; [@bib46]). Our study suggests that one potential advantage of such a system architecture is that, beyond simple signal activation, it may endow cells with a large dynamic range of receptor abundances to memorize stimulation levels of multiple extracellular ligands ([@bib24]; [@bib41]). Notably, signal-mediated removal has been reported for many other receptors and signaling systems, such as the G protein-coupled receptors (GPCRs) ([@bib16]), involved in various sensory systems, and AMPA-type glutamate receptors ([@bib23]), implicated in synaptic plasticity. Therefore, similar relative sensing mechanisms may be important in multiple other receptor-based signaling cascades and across different biological contexts.

Materials and methods {#s4}
=====================

Experimental methods {#s4-1}
--------------------

### Measurement of EGF signaling responses {#s4-1-1}

MCF10A cells were obtained from the ATCC and grown according to ATCC recommendations. Cell identity was confirmed by short tandem repeat (STR) profiling at the Dana-Farber Cancer Institute and cells were tested with the MycoAlert PLUS mycoplasma detection kit (Lonza) and found to be free of Mycoplasma prior to analyses. For experiments, 96 well plates (Thermo Scientific) were coated with type I collagen from rat tail (Sigma-Aldrich) by incubating plates with 65 µl of 4 mg/ml collagen I solution in PBS for 2 hr at room temperature, washed twice with PBS using a EL406 Microplate Washer Dispenser (BioTek), and then sterilized under UV light for 20 min prior to use. Cells were harvested during logarithmic growth and plated into collagen-coated 96 well plates using a EL406 Microplate Washer Dispenser. Cells were grown in 200 µl of complete medium for 24 hr, serum starved twice in starvation media (DMEM/F12 supplemented with 1% penicillin-streptomycin and 0.1% bovine serum albumin), incubated in 200 µl of starvation media for 19 hr, washed twice more, and incubated in 200 µl of starvation media for another hour. This time point constituted t = 0 for all experiments.

Treatment solutions were created by manual pipetting or by dispensing the appropriate amounts of epidermal growth factor (EGF, Peprotech), hepatocyte growth factor (HGF, Peprotech), or SC-79 (Sigma) into starvation media using a D300 Digital Dispenser (Hewlett-Packard). At t = 0 cells were stimulated with 100 µl of treatment solution and then incubated for the indicated times. For experiments requiring a second stimulus, cells were treated with an additional 100 µl of treatment solution at 3 hr and incubated for the indicated times. For fixation, 100 µl of supernatant were removed from the wells, replaced by 100 µl of 12% formaldehyde solution (Sigma) in phosphate buffered saline (PBS), and incubated for 30 min at room temperature.

All subsequent washes and treatments were performed with the EL406 Microplate Washer Dispenser. Cells were washed twice in PBS and permeabilized with 0.3% Triton X-100 (Sigma-Aldrich) in PBS for 30 min at room temperature (this step was omitted for measuring the surface expression of cMET and EGFR), washed once again in PBS, and blocked in 40 µl of Odyssey blocking buffer (LI-COR Biotechnology) for 60 min at room temperature. Cells were incubated with 30 µl of anti-phospho-Akt (Cell Signaling Technologies, 4060, 1:400), FoxO3 (Cell Signaling Technologies, 2497, 1:200), anti-Met (R and D Systems, AF276, 1:150), or anti-EGFR (Thermo Fisher Scientific, MA5-13319, 1:100) over night at 4°C. Cells were washed once in PBS and three times in PBS with 0.1% Tween 20 (Sigma-Aldrich; PBS-T for 5 min each and incubated with 30 µl of a 1:1000 dilution of secondary antibodies conjugated with Alexa Fluor 647 in Odyssey blocking buffer for 60 min at room temperature. Cells were washed two times in PBS-T, once with PBS, and stained for 30 min at room temperature with whole cell stain green (Thermo Fisher Scientific) and Hoechst (Thermo Fisher Scientific). Cells were washed three times in PBS, covered in 200 µl of PBS, and sealed for microscopy. Cells were imaged using an Operetta microscope (Perkin Elmer).

For the quantitative Western blots, about 70% confluent MCF10A cells were serum starved and treated with different concentrations of EGF (1, 0.56, 0.31, 0.18, 0.1 ng/mL). Cell lysate was prepared in Laemmili Sample Buffer (Bio-Rad) and subjected to SDS-PAGE in the 4--20% gradient gel (Bio-Rad). Western blots were performed using standard conditions with primary antibodies anti-phospho-EGFR (Cell Signaling Technologies, 3777, 1:1000) and anti-phospho-Akt (Cell Signaling Technologies, 4060, 1:1000) and anti-Actin (Santa Cruz Biotechnology, sc-47778 HRP, 1:5000). Secondary HRP-conjugated antibodies were acquired from Cell Signaling (7074, 1:10,000). Signals were detected with SuperSignal West Dura Extended Duration Substrate (Thermo Fisher Scientific) on a myECL Imager (Thermo Fisher Scientific) and analyzed by Image Studio Lite software (LI-COR Biosciences) by normalizing the signal from each antibody by the corresponding signal from Actin.

Image Processing {#s4-2}
----------------

Images were analyzed using the Columbus image data storage and analysis system (Perkin Elmer) to quantify single cell fluorescence measurements from each imaged well. The reported intensity values were obtained by first subtracting the background fluorescence of the well and subsequently the levels of pAKT at no stimulation at the same time. From each well we thus obtained a distribution of single cell measurements of a given target (pAkt, FoxO3, scMET or sEGFR). In each distribution we discarded the top and bottom 5% of points to remove outliers due to imaging and detection errors. The nuclear FoxO3 to cytoplasmic FoxO3 compartmentalization ratio was determined by the mean intensity in each area after image segmentation based on Hoechst and whole cell stain green at the single cell level. After that, we calculated the average of the resulting single cell distributions. For each condition, we performed multiple technical repeats (multiple wells), and as a final result reported the average of the corresponding single cell distribution averages and the associated standard deviations.

Computational methods {#s4-3}
---------------------

In this section, we describe in detail (1) the model of the EGF/EGFR/Akt signaling pathway, (2) model assumptions, (3) model parameters and their bounds, (4) various relevant biological constraints that were imposed while fitting the model to the data, (5) the error function that was minimized in the parameter search, (6) the numerical procedure used to minimize the error function between model predictions and experimental data, and (7) in silico predictions.

### General structure of the computational model {#s4-3-1}

The dynamic ODE model describing the EGF/EGFR signaling cascade leading to Akt phosphorylation ([Supplementary file 1a, b](#supp1){ref-type="supplementary-material"}, and [Equations A2--A20](#equ11){ref-type="disp-formula"}) was based on the previous work by [@bib11]. We retained the components of the model relevant to EGF-dependent phosphorylation of EGFR and the subsequent cascade responsible for Akt phosphorylation. The resulting model consisted of 20 chemical species (see [Supplementary file 1a](#supp1){ref-type="supplementary-material"}) and was described by 24 parameters (20 reaction rate constants and four total species concentrations, [Supplementary files 1](#supp1){ref-type="supplementary-material"}--[3](#supp3){ref-type="supplementary-material"}, and [Equations A2--﻿A20](#equ11 equ12 equ13 equ14 equ15 equ16 equ17 equ18 equ1 equ2 equ3 equ4 equ5){ref-type="disp-formula"}).

The model included processes across three cellular compartments: cell surface (plasma membrane), cytoplasm, and endosomes. The model included interactions of the ligand with the receptors (ligand-binding and unbinding to receptor monomers and dimers) and subsequent receptor dimerization and undimerization. The model also included internalization of phosphorylated and unphosphorylated receptors, their recycling and degradation, phosphorylation and dephosphorylation by phosphatases.

### Main assumptions of the model {#s4-3-2}

In agreement with available literature ([@bib56]; [@bib27]), we assumed that the rates of internalization, recycling, and degradation are different for inactive (unphosphorylated) and active (phosphorylated) receptors ([Supplementary file 1a](#supp1){ref-type="supplementary-material"}). We assumed that EGFR phosphatases in MCF10A cells are present at exceedingly high concentrations ([@bib33]), and therefore we implemented the corresponding reaction of dephosphorylation of phosphorylated EGFRs (pEGFRs) as a first order reaction. We further assumed that activated receptors on plasma membrane and in endosomes are dephosphorylated by the phosphatase with the same rate ([@bib33]).

We implemented PIP2 phosphorylation by pEGFR on the plasma membrane as a simplified effective first order process. Following the receptor-driven phosphorylation of PIP2 we retained the canonical signaling cascade of the PI3K/Akt activation ([Figure 2a](#fig2){ref-type="fig"} in the main text). We also implemented a first order reaction for action of the phosphatase on pAkt.

We assumed that cells are at steady state in terms of the abundances of ligand-free cell surface and endosomal receptors prior to ligand exposure. Specifically, prior to ligand exposure, the number of ligand-free EGFR monomers on cell surface and in endosomes, were derived based on the steady state condition of the corresponding equations.

In agreement with the literature ([@bib25]; [@bib43]), we assumed that Akt can be phosphorylated only by cell-surface pEGFR, and not by endosomal pEGFR. Finally, we assumed that over the course of simulation extracellular ligand concentration remained constant, unless a step increase in EGF was applied. Here we refer to the background ligand stimulation as stimulation applied at time t = 0 to the cells that were previously not exposed to the ligand.

### Model parameters {#s4-3-3}

The model parameters consisted of 4 total species abundances (PIP2, Akt, PDK1, and EGF receptors) and 20 rate constants. We collected multiple values of these parameters from literature ([Supplementary file 1a](#supp1){ref-type="supplementary-material"}). In our search for optimal rate parameters fitted to data, we allowed rate parameters to vary within half an order of magnitude from the lowest and the highest literature derived estimate ([Supplementary file 1a](#supp1){ref-type="supplementary-material"}). For parameters, for which experimental estimates were not available, we allowed up to four orders of magnitude in variation.

In addition, we allowed one and a half orders of variation in first order rate of EGF unbinding from receptors and the rate of EGFR phosphorylation in order to account for spatial organization of the receptors on the cell surface ([@bib37]). We fixed the rate of pEGFR phosphatase according to the measurement of this constant in MCF10A cells ([@bib33]). In accordance with literature parameter estimates ([Supplementary file 1a](#supp1){ref-type="supplementary-material"}), we constrained the rate of ligand unbinding, receptor undimerization, receptor phosphorylation, and receptor dephosphorylation to be at least 10 times faster than receptor internalization ([@bib55]; [@bib27]; [@bib11]; [@bib33]).

Total number of EGFR receptors was limited to be between 10^5^--10^6^ molecules per cell ([@bib42]). Total protein abundance of Akt was limited to be between 10^5^--10^6^ molecules per cell ([@bib11]). The abundance of PDK1 was limited between 10^3^--10^6^ molecules per cell ([@bib11]; [@bib52]). Total abundance of lipid molecule PIP2 was limited between 10^8.2^--10^9.2^. The abundance of PIP2 was calculated based on (1) surface area of MCF10A cells (calculated using a diameter of \~66 μm \[[@bib29]\] and assuming spherical cell shape), (2) total number of lipid molecules per 1 μm^2^ of membrane ([@bib3]) (\~5×10^6^), and (3) the fraction of PIP2 among all plasma membrane lipids ([@bib13]) (0.75%); this corresponded to \~5×10^8^ molecules of PIP2 per cell.

### Additional constraints {#s4-3-4}

In addition to the constraints imposed on network parameters directly through the experimentally measured data at EGF stimulations, we also required several additional constraints to better capture biology of EGFR signaling based on known literature. These constraints were either added as 'hard' constraints: parameter sets that did not agree with hard constraints were rejected, or as 'soft' constraints: parameter sets that did not agree with soft constraints were penalized using additional terms in the error function.

#### Hard constraints {#s4-3-4-1}

We constrained the total number of EGF receptors prior to EGF exposure to be between 10^5^--10^6^ per cell, and surface EGFR to be within 10^5^--10^6^ receptors per cell, in agreement with EGFR abundances reported for MCF10A cell lines ([@bib42]). In the model, the number of cell surface receptors was not a free parameter, but was calculated based on the steady state condition of the differential equations that describe the system.

#### Soft constraint {#s4-3-4-2}

We also implemented a 'soft' constraint that ensured realistic levels of phosphorylated Akt molecules. We required that at least 10% of total Akt gets phosphorylated at EGF doses close to Akt saturation, that is in our case 3.16 ng/ml EGF ([@bib11]).

### Error function {#s4-3-5}

The error function quantified the disagreement between model predictions and data and the soft constraints. At a given point *θ* in parameter space, we solved the system of ODEs describing EGF-induced Akt phosphorylation (see below) using the MATLAB and obtained model solutions {*S~i~}* for all experimentally measured conditions. Importantly, while the model predicts protein concentrations in units of number of molecules per cell, our experiments measured protein concentration up to a scaling factor. Therefore, we rescaled the model prediction using maximum likelihood linear-regression estimate (MLE) for both pAkt and sEGFR data between the model and the data respectively. Specifically, separately for pAkt and sEGFR, we fitted a linear model between the predictions from the ordinary differential equation model and the corresponding experimental measurements across multiple EGF doses and time points. We rescaled the predictions based on the slope and the intercept of the linear model fit. The scaled predictions were used in the evaluation of the error.

The error function comprised of two different contributions. The first term was defined as the sum of the squared differences between the model predictions {*S~i~}* at parameter value *θ* and the corresponding experimental data D, taking into account corresponding experimental errors σ s ([Equation S1a](#equ6){ref-type="disp-formula"}). Next, we imposed the soft constraints described above as squared error terms ([Equation S1b](#equ7){ref-type="disp-formula"}, and [Supplementary file 1b](#supp1){ref-type="supplementary-material"} for species abbreviation). The total error function was the sum of these two contributions ([Equation S1c](#equ8){ref-type="disp-formula"}).$${\hat{E}}_{1}\left( \theta \right) = \sum\limits_{k = 1}^{n}\frac{\left( {S_{k}\left( \theta \right) - D_{k}\ } \right)^{2}}{2\sigma_{k}^{2}}$$$${\hat{E}}_{2}\left( \theta \right) = \frac{\left( {f_{akt,max} - 0.1} \right)^{2}}{2 \times \left( 0.004 \right)^{2}}\ if\ f_{akt,max} < 0.1$$$$\hat{E}\left( \theta \right) = {\hat{E}}_{1}\left( \theta \right) + {\hat{E}}_{2}\left( \theta \right)$$where$$\hat{E}\left( \theta \right) = {\hat{E}}_{1}\left( \theta \right) + {\hat{E}}_{2}\left( \theta \right)$$

The standard deviation 0.004 in [Equation S1b](#equ7){ref-type="disp-formula"} was chosen to ensure that the maximum pAkt levels were guaranteed to be above 10% of total Akt levels. Lower values lead to a very high rejection rate in the simulated annealing procedure and higher values were likely to return parameter points that did not satisfy the constraint that maximum pAkt levels were at least 10% of total Akt levels. The active endocytosis and degradation of cell surface receptors in our system occurred mostly between EGF doses of 0 ng/ml and 3.16 ng/ml. Accordingly, we fit the model using experimental data collected in the same range of EGF stimulations.

The error function in [Equation 1 a](#equ1){ref-type="disp-formula"} contained the following experimentally measured data points: pAkt time courses measured up to 180 min (5, 10, 15, 30, 45, 90, and 180 min) across range of EGF doses between 0.03 and 3.16 ng/ml (0.03,0.1,0.3,1,3.16 ng/ml EGF) and sEGFR levels at 2.5 and 3 hr across a range of EGF stimulation doses (0 ng/ml and 0.03--3.16 ng/ml).

In [Equation 1 a](#equ1){ref-type="disp-formula"}, index *k* runs through all *n* experimentally measured data points (5 doses x 7 time points = 35 total points) and sEGFR measurements (6 doses x 2 time points = 12 total points).

Overall, the error function had a total of 50 terms (35 pAkt measurements, 12 sEGFR measurements, and one soft constraint). We minimized this error by searching through the parameter space using simulated annealing (SA) described in the next section.

### Simulated Annealing optimization {#s4-3-6}

Given that the mechanistic ODE models constrained by experimental measurements of several dynamical quantities are usually underdetermined ([@bib11]), we used simulated annealing (SA) ([@bib32]), to numerically search the model's parameter space.

The overall error ([Equation S1c](#equ8){ref-type="disp-formula"}) was minimized with SA in order to determine parameter sets that are most consistent with the experimental measurements. Following standard SA optimization scheme, we ran a random walk in the model's parameter space. At each point in the parameter space we accept or reject a next proposed parameter set according to the Metropolis criterion and a likelihood that is the negative exponential of the error function in [Equations S1a](#equ6){ref-type="disp-formula"}. Following a conventional SA protocol, we used an additional parameter, temperature, which allowed steps with relatively large change in the likelihood score to explore large parameter space. The temperature was decreased gradually to find a local minimum of the likelihood function.

To find multiple parameter sets that fit the experimental data, we ran 100 independent SA chains with randomly selected starting points spread out across allowed parameter ranges. Each chain was started at high temperature and was cooled down in 12 stages to the lowest temperature (using the sequence of temperatures: 400, 200, 100, 50, 20, 10, 5, 2, 1, 0.5, 0.25, 0.1). At each temperature, 1500 steps in parameter space were performed. In each step, on an average four randomly chosen parameters (out of the 24) were changed in order to speed up the search in the parameter space.

### Predictions from SA {#s4-3-7}

For individual chains, the parameter set with the lowest error was recorded. The averages of parameter values from the 10 best-fit chains are shown in [Supplementary file 1a](#supp1){ref-type="supplementary-material"}. We used these top 10 optimized parameter sets ([Supplementary file 1a](#supp1){ref-type="supplementary-material"}, [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}) to explore phenomenon of relative sensing in silico. For each parameter set, we simulated the following. The model was first exposed to the background EGF concentration for 50 hr to ensure that all species reached a steady state. The model was subsequently exposed to a step increase in EGF concentration (2-, 3-, 4-, or 6- fold). After the step increase, EGF was kept constant as well. We noted the maximum Akt phosphorylation level at each background concentration and EGF fold-change. For each fit, we obtained a series of maximum pAkt responses across different initial EGF concentrations and for multiple fold changes as well as time integrals of pAkt responses between 0 and 30 min. We combined the predicted relative sensing dose responses at every background EGF level and at every fold by taking the average (and the corresponding standard deviation) across predictions from all 10 best parameter sets. We then plot the resulting dose response as seen in [Figure 2c,d](#fig2){ref-type="fig"} of the main text.

### Statement of source code availability {#s4-3-8}

All data and source code are available at: <https://github.com/dixitpd/FoldChange> ([@bib14]; copy archived at <https://github.com/elifesciences-publications/FoldChange>).
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Analytical model of relative sensing {#s8}
====================================

Below we present the analytical model to understand the biochemical mechanisms underlying the observed relative sensing in the EGFR/Akt pathway. The model focuses on the receptors level signaling. Since Akt phosphorylation is directly downstream of receptor phosphorylation, the conclusions of the model hold for Akt phosphorylation as well.

In section 1 we show that after continuous exposure to an activiating ligand with concentration \[*L*\]~0~, the steady-state level of cell-surface receptors \[*R*\]*~T~* decreases approximately as the negative logarithm of the ligand concentration, that is \[*R*\]*~T~* \~ (*constant* -- log \[*L*\]~0~). In this way, the steady state abundance of cell surface receptors effectively encodes the memory of the background ligand concentration. In section 2, we show that the phosphorylation response induced by an increase in the extracellular ligand concentration from \[*L*\]~0~ to \[*L*\]~1~ depends approximately logarithmically on the ligand concentration and linearly on the current abundance of cell-surface receptors \[*R*\]*~T~*. Based on results derived in the secton 1 and section 2, we then demonstrate that the phosphorylation response of the signaling network to an increase in ligand concentration primarily depends on the relative fold increase in ligand concentration (\[*L*\]~1~/\[*L*\]~0~). In section 3, we use the analytical model to identify two dimensionless aggregate parameters (*α* and *β*) that determine the ranges of background ligand concetration where relative sensing can be observed. In section 4 we derive and analyze a similar analytical model for a signal transduction network in which the phopshorylation signal is initiated by monomeric receptors.

Main assumptions of the model {#s9}
-----------------------------

In the simplified analytical model, following experimental evidence ([@bib28]; [@bib36]) the prevailing mode of EGFR dimerization in the range of extracellular EGF concentrations that we consider is assumed to be one EGF-bound EGFR monomer bound to one ligand-free EGF receptor. While phosphorylated EGFRs can signal from both the plasma membrane and endosomes, some components of the PI3K/Akt signaling pathway are largely restricted to the plasma membrane. Consequently, Akt phosphorylation occurs primarily from the phosphorylated EGFRs localized at the plasma membrane ([@bib25]; [@bib43]). Thus, we assume that Akt molecules cannot get phosphorylated from phosphorylated EGFRs localized in the endosomes. We also assume that endosomal EGFR-bound EGF ligands do not dissociate from the receptors ([@bib45]). In the endosomes the model only allows receptor phosphorylation/dephosphorylation, recycling to plasma membrane, and degradation. We assume that the rates of phosphorylation and dephosphorylation are the same for cell surface receptors as well as internalized receptors. We also assume that rates of internalization, recycling, and degradation of phosphorylated (activated) receptors are different from those of the non-phosphorylated (non-activated) receptors. Finally, we assume that the extracellular ligand concentration remains constant at background stimulation and after the step increase in ligand concentration.

Section 1. steady state level of surface receptors {#s10}
--------------------------------------------------

First, we calculate the level of cell surface receptors at steady state when cells are exposed to a constant stimulus with ligand concentration \[*L*\]~0~. Given the aforementioned assumptions, [Equations A1-A8](#equ10 equ11 equ12 equ13 equ14 equ15 equ16 equ17){ref-type="disp-formula"} describe the dynamics of receptor signaling cascade in presence of ligand at concentration \[*L*\]~0~ ([Appendix 1---figure 1](#app1fig1){ref-type="fig"}). In [Equations A1-A8](#equ10 equ11 equ12 equ13 equ14 equ15 equ16 equ17){ref-type="disp-formula"} below, we use \* to denote phosphorylated receptors and the subscript *i* to denote endosomal receptors.$$\frac{d\left\lbrack R \right\rbrack}{dt} = k_{prod} - k_{1}\lbrack L\rbrack_{0}\lbrack R\rbrack + k_{- 1}\lbrack LR\rbrack - k_{2}\lbrack R\rbrack\lbrack LR\rbrack + k_{- 2}\lbrack LR_{2}\rbrack - k_{i}\lbrack R\rbrack + k_{rec}\lbrack R_{i}\rbrack$$$$\frac{d\left\lbrack {LR} \right\rbrack}{dt} = k_{1}\left\lbrack L \right\rbrack_{0}\left\lbrack R \right\rbrack - k_{- 1}\left\lbrack {LR} \right\rbrack - k_{2}\left\lbrack R \right\rbrack\left\lbrack {LR} \right\rbrack + k_{- 2}\left\lbrack {LR_{2}} \right\rbrack\  - \ k_{i}\left\lbrack {LR} \right\rbrack + k_{rec}\left\lbrack {LR_{i}} \right\rbrack$$$$\frac{d\left\lbrack {LR_{2}} \right\rbrack}{dt} = k_{2}\left\lbrack R \right\rbrack\left\lbrack {LR} \right\rbrack - k_{- 2}\left\lbrack {LR_{2}} \right\rbrack - k_{p}\left\lbrack {LR_{2}} \right\rbrack + k_{dp}\left\lbrack {LR_{2}^{\ast}} \right\rbrack - k_{i}\left\lbrack {LR_{2}} \right\rbrack + k_{rec}\left\lbrack {LR_{2i}} \right\rbrack$$$$\frac{d\left\lbrack {LR_{2}^{\ast}} \right\rbrack}{dt} = k_{p}\left\lbrack {LR_{2}} \right\rbrack - k_{dp}\left\lbrack {LR_{2}^{\ast}} \right\rbrack - k_{i}^{\ast}\left\lbrack {LR_{2}^{\ast}} \right\rbrack + k_{rec}^{\ast}\left\lbrack {LR_{2i}^{\ast}} \right\rbrack$$$$\frac{d\left\lbrack LR_{2}^{*} \right\rbrack}{dt} = k_{p}\left\lbrack {LR_{2}} \right\rbrack - k_{dp}\left\lbrack {LR_{2}^{*}} \right\rbrack - k_{i}^{*}\left\lbrack {LR_{2}^{*}} \right\rbrack + k_{rec}^{*}\left\lbrack L{R_{2}^{*}}_{i} \right\rbrack$$$$\frac{d\left\lbrack R_{i} \right\rbrack}{dt} = k_{i}\left\lbrack R \right\rbrack - k_{rec}\left\lbrack R_{i} \right\rbrack - k_{deg}\left\lbrack R_{i} \right\rbrack$$$$\frac{d\left\lbrack {LR_{2i}} \right\rbrack}{dt} = k_{i}\left\lbrack {LR_{2}} \right\rbrack\  + \ k_{dp}\left\lbrack {LR_{2i}^{\ast}} \right\rbrack - k_{p}\left\lbrack {LR_{2i}} \right\rbrack - k_{rec}\left\lbrack {LR_{2i}} \right\rbrack - k_{deg}\left\lbrack {LR_{2i}} \right\rbrack$$$$\frac{d\left\lbrack {LR_{2i}^{\ast}} \right\rbrack}{dt} = k_{i}^{\ast}\left\lbrack {LR_{2}^{\ast}} \right\rbrack + \ k_{p}\left\lbrack {LR_{2i}} \right\rbrack - k_{dp}\left\lbrack {LR_{2i}^{\ast}} \right\rbrack - k_{rec}^{\ast}\left\lbrack {LR_{2i}^{\ast}} \right\rbrack - k_{deg}^{\ast}\left\lbrack {LR_{2i}^{\ast}} \right\rbrack$$

-   [Equation A1](#equ10){ref-type="disp-formula"} describes the dynamics of the concentration \[*R*\] of ligand-free receptors. *k~prod~* is the rate of delivery of free receptors to cell surface, *k~1~* is the rate constant of ligand binding to receptors, *k~-1~* is the rate constant of ligand unbinding from the ligand-receptor complex, *k~2~* is the rate of receptor dimerization, *k~-2~* is the rate of receptor undimerization, *k~i~* is the basal internalization rate of non-activated receptors, and finally, *k~rec~* is the rate of recycling of internalized unphosphorylated receptors to cell surface.

-   [Equation A2](#equ11){ref-type="disp-formula"} describes dynamics of the concentration \[*LR*\] of the ligand bound non-activated monomeric receptors.

-   [Equation A3](#equ12){ref-type="disp-formula"} describes the dynamics of the concentration \[*LR*~2~\] of the unphosphorylated dimer species. *k~p~* is the rate of receptor phosphorylation and *k~dp~* is the rate of receptor dephosphorylation.

-   [Equation A4](#equ13){ref-type="disp-formula"} describes the dynamics of the concentration \[*LR*^\*^~2~\] of the phosphorylated dimer species. *k~i~^\*^* is the internalization rate of phosphorylated receptors and *k~rec~^\*^* is the rate of recycling of phosphorylated receptors.

-   [Equation A5](#equ14){ref-type="disp-formula"} describes the dynamics of the concentration \[*R~i~*\] of the internalized ligand-free receptor monomers. *k~deg~* is the rate of degradation of unphosphorylated receptors.

-   [Equation A6](#equ15){ref-type="disp-formula"} describes the dynamics of the concentration \[*LR~i~*\] of the internalized ligand-bound non-activated receptor monomers.

-   [Equation A7](#equ16){ref-type="disp-formula"} describes the dynamics of the concentration \[*LR*~2*i*~\] of the internalized unphosphorylated receptor dimers.

-   [Equation A8](#equ17){ref-type="disp-formula"} describes the dynamics of the concentration \[*LR*^\*^*~2i~*\] of the internalized phosphorylated receptors. *k^\*^~deg~* is the rate of degradation of phosphorylated receptors.

![Model schematics of dimer-activated receptors signaling cascade.](elife-50342-app1-fig1){#app1fig1}

In our calculations below we consider all concentrations (except for the ligand) to be measured on a per cell basis. For convenience we also introduce the following constants and equations:$$R_{0} = \frac{k_{prod}}{k_{i}} \times \frac{k_{deg} + k_{rec}}{k_{deg}}$$steady state abundance of surface receptors in the absence of ligand, *\[L\]*=0$$\left\lbrack R \right\rbrack_{T} = \left\lbrack R \right\rbrack + \left\lbrack {LR} \right\rbrack + 2\left\lbrack {LR_{2}} \right\rbrack + 2\left\lbrack {LR_{2}^{\ast}} \right\rbrack$$the total cell-surface receptor level at steady state$$K_{d1} = \frac{k_{- 1}}{k_{1}}$$the equlibrium dissociation constant of ligand binding to receptors.$$K_{d2} = \frac{k_{2}}{k_{- 2}}$$the equilibrium constant of the undimerization reaction.$$K_{d2} = \frac{k_{2}}{k_{- 2}}$$the ligand concentration relative to the ligand-receptor equilibrium dissociation constant

We note that *K~d~*~1~ has the units of moles and *K~d2~* has the units of molecules per cell (same as *R~0~*), and $u_{0} = \frac{\left\lbrack L \right\rbrack_{0}}{K_{d1}}$ is a dimensionless quantity.

As has been previously reported ([@bib56]) and as was also observed in our experimental system, surface EGFR levels reach quasi-steady state within hours of continuous stimulation with EGF (main text [Figure 1c](#fig1){ref-type="fig"}). Importantly, ligand unbinding, receptors undimerization, and receptor phosphporylation-dephosphprylation happen at a substantially faster rate than basal receptor internalization ([@bib11]; [@bib33]). Moreover, when we substitute the average parameter values from the fits to the computational model (main text and Methods), we have:$$\begin{matrix}
{\frac{k_{- 1}}{k_{i}} \sim \frac{0.3\ s^{- 1}}{1.5 \times 10^{- 4}s^{- 1}} \sim \ 2000 \gg \ 1,} \\
{\frac{k_{- 2}}{k_{i}} \sim \frac{0.05\ s^{- 1}}{1.5 \times 10^{- 4}s^{- 1}} \sim \ 380 \gg 1,} \\
{\frac{k_{p}}{k_{i}} \sim \frac{1\ s^{- 1}}{1.5 \times 10^{- 4}s^{- 1}} \sim 7000 \gg 1,} \\
{\frac{k_{dp}}{k_{i}} \sim \frac{0.07\ s^{- 1}}{1.5 \times 10^{- 4}s^{- 1}} \sim 480 \gg 1} \\
\end{matrix}$$

From [Equations A1-A8](#equ10 equ11 equ12 equ13 equ14 equ15 equ16 equ17){ref-type="disp-formula"} and the limits imposed by inequalities A14, we calculate the receptor level at steady state with continuous exposure to the ligand by setting the rates of change of individual concentrations to zero. Based on the available knowledge about the biology of EGF receptors and parameters of our model ([Equations A14](#equ23){ref-type="disp-formula"}), we neglect the internalization and recycling of ligand-bound monomers and unphosphorylated dimers. Consequently, we neglect degradation of ligand-bound receptor monomers and unphosphorylated receptor dimers. As a result, we assume that at steady state, the fraction of monomeric ligand bound receptors in the endosomes is negligible. We have$$0 = k_{prod} - k_{1}\left\lbrack L \right\rbrack_{0}\left\lbrack R \right\rbrack + k_{- 1}\left\lbrack {LR} \right\rbrack - k_{2}\left\lbrack R \right\rbrack\left\lbrack {LR} \right\rbrack + k_{- 2}\left\lbrack {LR_{2}} \right\rbrack - k_{i}\left\lbrack R \right\rbrack + k_{rec}\left\lbrack R_{i} \right\rbrack$$$$0 = k_{prod} - k_{1}\left\lbrack L \right\rbrack_{0}\left\lbrack R \right\rbrack + k_{- 1}\left\lbrack {LR} \right\rbrack - k_{2}\left\lbrack R \right\rbrack\left\lbrack LR \right\rbrack + k_{- 2}\left\lbrack LR_{2} \right\rbrack - k_{i}\left\lbrack R \right\rbrack + k_{rec}\left\lbrack R_{i} \right\rbrack$$$$0 = k_{1}\left\lbrack L \right\rbrack_{0}\left\lbrack R \right\rbrack - k_{- 1}\left\lbrack {LR} \right\rbrack - k_{2}\left\lbrack R \right\rbrack\left\lbrack {LR} \right\rbrack + k_{- 2}\left\lbrack {LR_{2}} \right\rbrack$$$$0 = k_{2}\left\lbrack R \right\rbrack\left\lbrack {LR} \right\rbrack - k_{- 2}\left\lbrack {LR_{2}} \right\rbrack - k_{p}\left\lbrack {LR_{2}} \right\rbrack + k_{dp}\left\lbrack {LR_{2}^{*}} \right\rbrack$$$$0 = k_{p}\left\lbrack {LR_{2}} \right\rbrack - k_{dp}\left\lbrack {LR_{2}^{*}} \right\rbrack - k_{i}^{*}\left\lbrack {LR_{2}^{*}} \right\rbrack + k_{rec}^{*}\left\lbrack L{R_{2}^{*}}_{i} \right\rbrack$$$$0 = k_{i}\left\lbrack R \right\rbrack - k_{rec}\left\lbrack R_{i} \right\rbrack - k_{deg}\left\lbrack R_{i} \right\rbrack$$$$0 = k_{dp}\left\lbrack {LR_{2_{i}}^{*}} \right\rbrack - k_{deg}\left\lbrack LR_{2_{i}} \right\rbrack - k_{p}\left\lbrack {L{R_{2}}_{i}} \right\rbrack$$

Solving for steady state [Equations A15-A21](#equ24 equ25 equ26 equ27 equ28 equ29 equ30){ref-type="disp-formula"} when ligand concentration is \[*L*\]~0~ = *u~0~*\**K~d1~*, we obtain the formula for the total number of receptors on the cell surface,$$\ \left\lbrack R \right\rbrack_{T} = 2R_{0}\left\lbrack {\frac{1 + u_{0}}{1 + \sqrt{1 + 8\alpha\beta u_{0}}} + \frac{2\alpha u_{0}}{1 + 4\alpha\beta u_{0} + \sqrt{1 + 8\alpha\beta u_{0}}}} \right\rbrack \approx \frac{2R_{0}}{1 + \sqrt{1 + 8\alpha\beta u_{0}}}$$where we have introduced two aggregate parameters that we denote *α* and *β* (see [Equations A23a and A23](#equ32 equ32){ref-type="disp-formula"}b below).

The first term in [Equation A22](#equ31){ref-type="disp-formula"} represents the concentration of monomeric surface receptors (ligand-free \[*R*\] and ligand-bound monomeric receptors \[*LR*\]) at steady state, the second term represents the steady state concentration of dimeric receptors (unphosphorylated dimers \[*LR*~2~\] and phosphorylated receptors \[*LR*^\*^~2~\]). When the ligand concentration is much lower than the equilibrium dissociation constant; *u~0~* \<\<1, we can assume that the majority of cell surface receptors are ligand free as indicated in the second approximation in [Equation A22](#equ31){ref-type="disp-formula"}.

Remarkably, even though [Equations A1-A8](#equ10 equ11 equ12 equ13 equ14 equ15 equ16 equ17){ref-type="disp-formula"} are governed by more than ten rate parameters, the total concentration of receptors on the surface \[*R*\]*~T~* at steady state depends only on two composite aggregate parameters α and β and the ligand concentration *u~0~.* The two aggregate parameters are defined as,$$\alpha = \frac{k_{dp} + k_{p}}{k_{dp}} \times \frac{R_{0}}{K_{d2}},$$$$\alpha = \frac{k_{p} + k_{dp}}{k_{dp}} \times \frac{R_{0}}{K_{d2}}$$

The parameter *α* quantifies the ligand-sensitivity of the signaling system, an increase in the value of *α* leads to a higher signal sensitivity and an increase in receptor dimerization and phosphorylation. The parameter *β* quantifies the combination of two biases leading to preferential internalization and degradation of phosphorylated receptors. An increase in the value of *β* leads to a larger fraction of active (phosphorylated) receptors being internalized and degraded. The first term in A23b is the fraction of dimeric receptors that are phosphorylated. The second term *k^\*^~i~/k~i~* is the relative rate at which phosphorylated receptors are trafficked to the endosomes compared to unphosphorylated receptors. Finally, the third term quantifies the ratio of the two following fractions; *k^\*^~deg~/(k^\*^~rec~ + k^\*^~deg~)* is the fraction of phosphorylated receptors that are transported from endosomes to be degraded and *k~deg~/(k~rec~ + k~deg~)* is the fraction of unphosphorylated receptors that are transported from endosomes to be degraded.

Using average values of parameters from our dynamical ODE model fits (Materials and methods and [Supplementary files 1](#supp1){ref-type="supplementary-material"}, [2](#supp2){ref-type="supplementary-material"}, [3](#supp3){ref-type="supplementary-material"}), we estimate *α* \~16 and *β* \~40. From here onwards, we use these two values of *α* and *β* in our analysis. In [Appendix 1---figure 2](#app1fig2){ref-type="fig"} we plot the steady state cell surface EGFR levels predicted by [Equation A22](#equ31){ref-type="disp-formula"} as a function of the continuous background ligand stimulation *u*~0~ for these values of *α* and *β*. Notably, the receptor levels decrease approximately logarithmically as a function of *u*~0~ over nearly two orders of magnitude in ligand concentration between *u~0~* \~10^-3.5^ -- 10^−2^.

![Steady state receptor levels decrease proportional to the logarithm of ligand concentration.\
The steady state cell surface receptor level \[*R*\]*~T~* for receptors (black line) given by [Equation (A22)](#equ31){ref-type="disp-formula"} depends approximately on the logarithm of the ligand concentration *u*~0~ = \[*L*\]~0~/*K*~d1~ (red line, [Equations A24](#equ34){ref-type="disp-formula"}). The inflection point is indicated by a green dot.](elife-50342-app1-fig2){#app1fig2}

The logarithmic dependence can be quantified as follows. \[*R*\]*~T~* in [Equation A22](#equ31){ref-type="disp-formula"} has an inflection point with respect to the logarithm of the ligand concentration; $\beta = \frac{k_{p}}{k_{dp} + k_{p}} \times \frac{k_{i}^{*}}{k_{i}} \times \frac{\frac{k_{deg}^{*}}{k_{deg}^{*} + k_{rec}^{*}}}{\frac{k_{deg}}{k_{deg + k_{rec}}}}$ at $\frac{d^{2}\left\lbrack R \right\rbrack_{T}}{d{{\log u}_{0}}^{2}} = 0$. Near the inflection point, \[*R*\]*~T~* can be approximated as a log-linear function of *u~0~.* Expanding [Equation A22](#equ31){ref-type="disp-formula"} near $u_{0} = u_{flex} = \frac{1 + \left. \sqrt{}2 \right.}{4\alpha\beta}$, we have$$r = \frac{\ \left\lbrack R \right\rbrack_{T}}{R_{0}} \approx constant - a\log u_{0}$$where $a = 3 - 2\sqrt{2}$. Notably, $r = \frac{{\left\lbrack R \right\rbrack}_{T}}{R_{0}} \approx constant - a{\log u_{0}}$ does not depend on *α* and *β*. Here *r* is the fraction of receptors remaining on the cell surface.

Section 2. Relative sensing of extracellular ligand by the signaling cascade {#s11}
----------------------------------------------------------------------------

In this section, using a surface-receptor level analytical model, we show that receptor phosphorylation can sense relative changes in extracellular ligands. Based on the equation for the total number of receptors at the steady-state obtained in the previous section, we calculate here the maximum of the EGFR phosphorylation level in response to an instant change in EGF concentration from a background level \[*L*\]~0~ to a new level \[*L*\]~1~.

Main assumptions of the model. We assume that the dynamic maximum of the phosphorylation response is reached through the rapid equilibration between ligand binding and unbinding and receptor phosphorylation and dephoshorylation and assume no contribution from relatively slow receptor internalization ([@bib33]). Consequently, at the time phosphorylated EGFRs reach their maximum level, the total number of receptors on the cell surface, \[*R*\]*~T~*, is approximately similar to the steady state level determined by the pre-exposure to ligand concentration of \[*L*\]~0~. With these approximations, we have at pseudo-steady state conditions at the maximum pEGFR activity:$$0 = - k_{1}\left\lbrack L \right\rbrack_{1}\left\lbrack R \right\rbrack + k_{- 1}\left\lbrack {LR} \right\rbrack - k_{2}\left\lbrack R \right\rbrack\left\lbrack {LR} \right\rbrack + k_{- 2}\left\lbrack {LR_{2}} \right\rbrack$$$$0 = k_{1}\left\lbrack L \right\rbrack_{1}\left\lbrack R \right\rbrack - k_{- 1}\left\lbrack {LR} \right\rbrack - k_{2}\left\lbrack R \right\rbrack\left\lbrack {LR} \right\rbrack + k_{- 2}\left\lbrack {LR_{2}} \right\rbrack$$$$0 = k_{2}\left\lbrack R \right\rbrack\left\lbrack {LR} \right\rbrack - k_{- 2}\left\lbrack {LR_{2}} \right\rbrack - k_{p}\left\lbrack {LR_{2}} \right\rbrack + k_{dp}\left\lbrack {LR_{2}^{\ast}} \right\rbrack$$$$0 = k_{p}\left\lbrack {LR_{2}} \right\rbrack - k_{dp}\left\lbrack {LR_{2}^{\ast}} \right\rbrack$$$$\left\lbrack R \right\rbrack_{T} = \left\lbrack R \right\rbrack + \left\lbrack {LR} \right\rbrack + 2\left\lbrack {LR_{2}} \right\rbrack + 2\left\lbrack {LR_{2}^{\ast}} \right\rbrack$$

Solving [Equations A25, A26, A27, A28, A29](#equ35 equ1 equ36 equ1 equ37 equ1 equ38 equ1 equ39){ref-type="disp-formula"} for maximum pEGFR level of active receptors *\[LR~2~^\*^\]*, we get$$\left\lbrack {LR_{2}^{\ast}} \right\rbrack_{\ } = \frac{k_{p}R_{0}}{k_{dp} + k_{p}} \times r_{\ }\left\lbrack {\frac{1}{2} - \frac{1}{1 + \sqrt{1 + \frac{8\alpha u_{1}}{\left( {1 + u_{1}} \right)^{2}} \times r}}} \right\rbrack \approx \frac{k_{p}R_{0}}{k_{dp} + k_{p}} \times r_{\ }\left\lbrack {\frac{1}{2} - \frac{1}{1 + \sqrt{1 + 8\alpha u_{1}r}}} \right\rbrack$$

The leading term ${\left\lbrack {LR}_{2}^{*} \right\rbrack}_{} = {\frac{k_{p}R_{0}}{k_{dp} + k_{p}} \times r}_{}\left\lbrack {\frac{1}{2} - \frac{1}{1 + \sqrt{1 + \frac{8{\alpha u}_{1}}{\left\lbrack {1 + u_{1}} \right\rbrack^{2}} \times r}}} \right\rbrack \approx {\frac{k_{p}R_{0}}{k_{dp} + k_{p}} \times r}_{}\left\lbrack {\frac{1}{2} - \frac{1}{1 + \sqrt{1 + 8\alpha u_{1}r}}} \right\rbrack$ in [Equation A30](#equ40){ref-type="disp-formula"} is a constant that determines only the overall strength of the response. From here onwards, we neglect it. Note that in [Equation A30](#equ40){ref-type="disp-formula"}, the total receptor concentration *r* depends on the background ligand concentration \[*L*\]~0~ before a step increase in the ligand concentration (see [Equation A22](#equ31){ref-type="disp-formula"}). The result of substituting the expression for the receptor level ([Equation A22](#equ31){ref-type="disp-formula"}) in [Equation A30](#equ40){ref-type="disp-formula"} cannot be written down as a simple analytical expression. In [Appendix 1---figure 3](#app1fig3){ref-type="fig"}, we numerically examine how \[*LR*^\*^~2~\], given by [Equation A30](#equ40){ref-type="disp-formula"}, depends on the fold change in ligand concentration, that is \[*L*\]~1~/\[*L*\]~0~, at different background ligand concentrations *\[L\]~0~*. Notably, \[*LR*^\*^~2~\] mostly depends on the ratio \[*L*\]~1~/\[*L*\]~0~ and only weakly on the background exposure levels \[*L*\]~0~ over an order of magnitude in background ligand concentration.

![The maximum of the EGFR phosphorylation response \[*LR*\*~2~\] as a function of ligand concentration *u~0~* before step change in ligand concentration for fold changes *u~1~/u~0~* in ligand concentration ranging from *u~1~/u~0~* = 2 (black) to *u~1~/u~0~* = 6 (red).\
The phosphorylation response is estimated using [Equation A30](#equ40){ref-type="disp-formula"}.](elife-50342-app1-fig3){#app1fig3}

The relative sensing phenomenon can be intuitively understood by considering an approximation to Equation A30 that allows us to quantify the contribution of ligand stimulation and steady state receptor levels in maximum phosphorylated EGFR response. As seen above, for a given background concentration $u_{0}$ the corresponding steady state receptor level $r$ decreases approximately as the logarithm of the background concentration near $u_{0} = u_{flex}$ of the relationship between ligand concentration and steady state receptor level ([Equation A22](#equ31){ref-type="disp-formula"}). When $r$, $u_{0} = u_{flex}$ Similarly, the phosphorylation response \[*LR*\*~2~\] upon a step change in ligand concentration from $r = r_{flex} = 2 - \sqrt{2}.$ to $u_{1}$ can also be approximated as a log-linear function of the ligand concentration $u_{1}$ near $u_{1}$ Here $u_{1} = \frac{1 + \left. \sqrt{}2 \right.}{4r\alpha}.$ is the steady state cell surface EGFR levels after exposing the cells to a background ligand concentration $r$. To understand how \[*LR*\*~2~\] depends separately on $u_{1}$ and $r$, we expand using, Taylor series, \[*LR*\*~2~\] given by [Equation A30](#equ40){ref-type="disp-formula"} linearly in $u_{1} = \frac{1 + \left. \sqrt{}2 \right.}{4r\alpha}.$ and log-linearly in $r$ near $u_{1}$ and $r = r_{flex}$ We have$$u_{1} = \frac{1 + \left. \sqrt{}2 \right.}{4r_{flex}\alpha}.$$where $b = \left( {5 - \frac{7}{\sqrt{2}}} \right)$ and $c = \left( {1 - \frac{1}{\sqrt{2}}} \right)$.

In [Appendix 1---figure 4](#app1fig4){ref-type="fig"}, we show a direct comparison between the phosphorylation response as predicted by [Equation A30](#equ40){ref-type="disp-formula"} as well as its approximation given by [Equation A31](#equ41){ref-type="disp-formula"}. We evaluate the phosphorylation response at *r* = *r~flex~* by varying the ligand concentration *u~1~* between *u~1~* = 10^−2^-10^-0.75^.The x-coordinate corresponds to the phosphorylation response predicted by [Equation A30](#equ40){ref-type="disp-formula"} and the y-coordinate corresponds to the phosphorylation response predicted by [Equation A31](#equ41){ref-type="disp-formula"}. Individual data points are represented as black circles. The dashed red line represents the line y = x. From [Appendix 1---figure 4](#app1fig4){ref-type="fig"}, it is clear that [Equation A31](#equ41){ref-type="disp-formula"} agrees very well with [Equation A30](#equ40){ref-type="disp-formula"} over a broad range of variation in ligand concentrations.

![Comparison between the phosphorylation response as predicted by [Equation A30](#equ40){ref-type="disp-formula"} (x-axis) and its approximation, [Equation A31](#equ41){ref-type="disp-formula"} (y-axis).\
We varied the ligand concentration *u~1~* between *u~1~* = 10^−2^-10^-0.75^. The black dots represent individual data points and the dashed red line represents x = y line.](elife-50342-app1-fig4){#app1fig4}

Substituting the log-linear relationship between *r* and the background ligand concentration *u~0~* given by [Equation A24](#equ34){ref-type="disp-formula"} we have$$c = \left( {1 - \frac{1}{\sqrt{2}}} \right).$$$$\left\lbrack {LR_{2}^{*}} \right\rbrack \approx constant + b{\log u_{1}} + c \times r \approx constant + b{\log u_{1}} - c \times a{\log u_{0}}$$

[Equation A33](#equ43){ref-type="disp-formula"} follows from [Equation A32](#equ42){ref-type="disp-formula"} because$$\left. \Rightarrow\left\lbrack {LR_{2}^{*}} \right\rbrack \approx constant + b{\log\frac{u_{1}}{u_{0}}} \right.$$

Consequently, the phosphorylation response after a step change in ligand concentration mostly depends on the ratio of ligand concentrations rather than on the background ligand concentration.

Section 3. Aggregate network parameters determine the range of relative sensing {#s12}
-------------------------------------------------------------------------------

In this section we explore whether the observed relative sensing is a result of *fine-tuning* of rate parameters in the EGF/EGFR pathway or if it is a robust phenomenon that is relatively insensitive to parameter variations.

The analysis of the model shows that the maximum phosphorylation response \[*LR*\*~2~\] ([Equation A30](#equ40){ref-type="disp-formula"}) primarily depends on two aggregate parameters *α* and *β* ([Equations A23a and A23b](#equ32 equ33){ref-type="disp-formula"}). In order to compare phosphorylation response at different values of *α* and *β*, we define the scaled phosphorylation response \[*LR*\*~2~\] (scaled) by normalizing \[*LR*\*~2~\] by its maximum over the background ligand concentration \[*L*\]~0~ at a fixed value of α and *β.* Such a scaled phosphorylation response varies between zero and one for all values of \[*L*\]~0~, \[*L*\]~1~, α, and *β.*

Using as an example a fold change of 6, \[*L*\]~1=~6x\[*L*\]~0,~ in [Appendix 1--- figure 5](#app1fig5){ref-type="fig"} we show \[*LR*\*~2~\] (scaled) as a function of background ligand concentration at different values of *α* (panel a) and *β* (panel b). The different colors represent different accuracy values of relative sensing. For example, the color red represents the range of background ligand concentrations over which the phosphorylation response is within 90% of the maximum (10% deviation). The color yellow represents the range of background ligand concentrations over which phosphorylation response is within 80% of the maximum (20% deviation) and so on. Vertical green lines indicate the region of 90% accuracy; the phosphorylation response \[*LR*\*~2~\] (scaled) varies within 10% of the maximum. Notably, as α increases, corresponding to a larger fraction of receptors that get phosphorylated, the span of background concentrations over which signaling network exhibits relative sensing increases as well. In panel b), we show \[*LR*\*~2~\] (scaled) as a function of background ligand concentration at different values of *β*. As *β* increases, the range of background concentrations over which relative sensing holds increases as well. The green arrows show the range of background ligand concentrations over which relative sensing holds for the values of *α* and *β* evaluated from the model fits to the data.

![Dimensionless parameters α and β dictate the range of relative sensing phenomenon.\
(**a**) Scaled phosphorylation response \[*LR*\*~2~\] as a function of background ligand concentration *u*~0~ = \[*L*\]~0~/*K~d1~* for different values of α and fold change *u~1~/u~0~* = 6 when *β* was fixed to *β* = 40. The colors represent scaled phosphorylation response. The dashed green lines sketch the range of concentrations *u~0~*where \[*LR*\*~2~\] is insensitive to the initial ligand concentration *u~0~*. (**b**) Scaled \[*LR*\*~2~\] as a function of *u~0~* for different values of *β* and fold change *u~1~/u~0~* = 6 when *α* was fixed to *α* = 16. The dashed green lines sketch the range of concentrations *u~0~* where phosphorylation response \[*LR*\*~2~\] is insensitive to the background ligand levels. The green arrows show the range of background ligand concentrations over which relative sensing holds for the values of *α* and *β* evaluated from the model fits to the data.](elife-50342-app1-fig5){#app1fig5}

In summary, the analytical model showed that cells adjust the number of receptors on their plasma membranes in response to background ligand exposures through preferential internalization and subsequent degradation of activated receptors. This effectively allows cells to encode the memory of background ligand exposures on the plasma membrane. The model identified two dimensionless aggregate parameters *α* and *β* that dictate the range of background ligand concentrations over which the signaling network can sense relative changes in extracellular ligand concentration. In agreement with experimental data ([Figure 3](#fig3){ref-type="fig"} in main text), the model showed that the relative sensing is observed over an order of magnitude in background ligand exposures and is several orders of magnitude below the equilibrium dissociation constant of the ligand with the receptors. Notably, the model showed that relative sensing was robust to variations in *α* and *β*.

Section 4. An analytical model for receptors internalization-based relative sensing for a case of monomer-activated receptors signaling {#s13}
---------------------------------------------------------------------------------------------------------------------------------------

Section 4.1 In this section, we show that relative sensing of extracellular ligand concentration can also occur for signaling cascades where receptor phosphorylation (activation) is initiated by ligand-bound receptor monomers instead of dimers. Therefore, receptor dimerization is not a necessary condition for relative sensing. The derivation of analytical expressions for the monomeric case follows the same general logic used in Sections 1 and 2 above.

Similar to the dimer case, we assume that signal transduction to a downstream target P ([Appendix 1---figure 6](#app1fig6){ref-type="fig"}) occurs largely through membrane-bound activated receptors and neglect activation due to endosomal phosphorylated receptors.

![Simplified schematics of the steady state analytical model of monomer-activated receptor signaling.](elife-50342-app1-fig6){#app1fig6}

First, we derive the expression for the steady-state cell surface receptor abundance after continuous exposure to the ligand at concentration \[*L*\]~0~. We demonstrate that the receptor level depends approximately logarithmically on the ligand concentration. Then, we derive the expression for the maximum phosphorylation in response to a step increase in extracellular ligand concentration. Notably, we show that the phosphorylation response only weakly depends on the background ligand dose and primarily reflects the fold change in ligand concentration.

The dynamics of species in the model is described by the following equations.$$\frac{d\left\lbrack R \right\rbrack}{dt} = k_{prod} - k_{1}\left\lbrack L \right\rbrack_{0}\left\lbrack R \right\rbrack + k_{- 1}\left\lbrack {LR} \right\rbrack - k_{i}\left\lbrack R \right\rbrack + k_{rec}\left\lbrack R_{i} \right\rbrack$$$$\frac{d\left\lbrack {LR} \right\rbrack}{dt} = k_{1}\left\lbrack L \right\rbrack_{0}\left\lbrack R \right\rbrack - k_{- 1}\left\lbrack {LR} \right\rbrack - k_{i}\left\lbrack {LR} \right\rbrack + k_{rec}\left\lbrack {LR_{i}} \right\rbrack - k_{p}\left\lbrack {LR} \right\rbrack + k_{dp}\left\lbrack {LR^{\ast}} \right\rbrack$$$$\frac{d\left\lbrack {LR^{\ast}} \right\rbrack}{dt} = k_{p}\left\lbrack {LR} \right\rbrack - k_{dp}\left\lbrack {LR^{\ast}} \right\rbrack - k_{i}^{\ast}\left\lbrack {LR^{\ast}} \right\rbrack + k_{rec}^{\ast}\left\lbrack {LR_{i}^{\ast}} \right\rbrack$$$$\frac{d\left\lbrack R_{i} \right\rbrack}{dt} = k_{i}\left\lbrack R \right\rbrack - k_{rec}\left\lbrack R_{i} \right\rbrack - k_{deg}\left\lbrack R_{i} \right\rbrack$$$$\frac{d\left\lbrack {LR_{i}} \right\rbrack}{dt} = k_{i}\left\lbrack {LR} \right\rbrack - k_{rec}\left\lbrack {LR_{i}} \right\rbrack - k_{deg}\left\lbrack {LR_{i}} \right\rbrack - k_{p}\left\lbrack {LR_{i}} \right\rbrack + k_{dp}\left\lbrack {LR_{i}^{\ast}} \right\rbrack$$$$\frac{d\left\lbrack {LR_{i}^{\ast}} \right\rbrack}{dt} = k_{i}^{\ast}\left\lbrack {LR^{\ast}} \right\rbrack - k_{rec}^{\ast}\left\lbrack {LR_{i}^{\ast}} \right\rbrack - k_{deg}^{\ast}\left\lbrack {LR_{i}^{\ast}} \right\rbrack\  + k_{p}\left\lbrack {LR_{i}} \right\rbrack - k_{dp}\left\lbrack {LR_{i}^{\ast}} \right\rbrack$$

[Equations A35-A40](#equ45 equ46 equ47 equ48 equ49 equ50){ref-type="disp-formula"} describe dynamics of \[*R*\], ligand-free receptor monomers, \[*LR*\], ligand-bound non-activated (unphosphorylated) receptor species, \[*LR\**\], ligand-bound activated receptor species, and their internalized counterparts \[*R~i~*\], \[*LR~i~*\] and \[*LR~i~\**\]. The conventions for the rate constants are the same as for the dimer model (section one above).

For convenience, we also introduce the following notations:$$\frac{d\left\lbrack LR_{i}^{*} \right\rbrack}{dt} = k_{i}^{*}\left\lbrack {LR^{*}} \right\rbrack - k_{rec}^{*}\left\lbrack {LR_{i}^{*}} \right\rbrack - k_{deg}^{*}\left\lbrack {LR_{i}^{*}} \right\rbrack + k_{p}\left\lbrack {LR_{i}} \right\rbrack - k_{dp}\left\lbrack LR_{i}^{*} \right\rbrack$$steady-state surface receptor level in the absence of extracellular ligand, \[L\]~0~ = 0$$R_{0} = \frac{k_{prod}}{k_{i}} \times \frac{k_{rec} + k_{deg}}{k_{deg}}$$the total number of receptors on the cell surface at steady state$$\left\lbrack R \right\rbrack_{T} = \left\lbrack R \right\rbrack + \left\lbrack {LR} \right\rbrack + \left\lbrack {LR}^{*} \right\rbrack$$equilibrium dissociation constant of ligand binding to its receptors$$K_{d} = \frac{k_{- 1}}{k_{1}}$$the ligand concentration relative to the ligand-receptor dissociation constant

As in the case of dimers-activated signaling, we solved [Equations A35-A40](#equ45 equ46 equ47 equ48 equ49 equ50){ref-type="disp-formula"} for the steady state value \[*R*\]*~T~* of the cell surface receptor level. Similar to the dimer case, we assume that ligand binding/unbinding and receptor phosphorylation/dephosphorylation happen at a time scale much faster than internalization of inactive receptors. In that limit, we have,$$u_{0} = \frac{\left\lbrack L \right\rbrack_{0}}{K_{d}}$$where κ and β are dimensionless constants given by$$\left\lbrack R \right\rbrack_{T} \approx R_{0} \times \frac{1}{1 + \beta \times \kappa \times u_{0}}$$

The dependence of \[*R*\]*~T~/R~0~* on the ligand concentration $u_{0}$ is shown in [Appendix 1---figure 7](#app1fig7){ref-type="fig"}. As an illustration, we use β = 40 and κ = 20. Similar to the dimer case, the surface receptor concentration \[*R*\]*~T~* depends approximately logarithmically on the ligand concentration near $u_{0}$ \~ 1/βκ.

![Steady state receptor levels decrease proportional to the logarithm of ligand concentration.\
The steady state cell surface receptor level \[*R*\]*~T~* for monomeric receptors (black line) given by [Equation A45](#equ55){ref-type="disp-formula"} depends approximately on the logarithm of the ligand concentration *u*~0~ = \[*L*\]~0~/*K*~d~ (red line). The green point represents the inflection point.](elife-50342-app1-fig7){#app1fig7}

Section 4.2 Next, using the equation for the total number of cell surface receptors at the steady-state obtained in the previous section we calculated the maximum phosphorylation level in response to an instant change in ligand concentration from a background level \[*L*\]~0~ to a new level \[*L*\]~1~.

Assumptions. We assume that the dynamic maximum of the phosphorylation response is reached through the rapid equilibration between ligand binding and receptor phosphorylation and dephosphorylation and assume no contribution from relatively slow receptor degradation ([@bib33]). Consequently, at the time phosphorylated receptors reach their maximum level, the total number of receptors on the cell surface, \[*R*\]*~T~*, remains approximately the same as the steady state level determined by the pre-exposure to ligand concentration of \[*L*\]~0~. With these approximations, we have at pseudo-equilibrium conditions at the maximum phosphorylated receptor activity:$$0 = - k_{1}\left\lbrack L \right\rbrack_{1}\left\lbrack R \right\rbrack + k_{- 1}\left\lbrack {LR} \right\rbrack$$$$0 = k_{1}\left\lbrack L \right\rbrack_{1}\left\lbrack R \right\rbrack - k_{- 1}\left\lbrack {LR} \right\rbrack - k_{p}\left\lbrack {LR} \right\rbrack + k_{dp}\left\lbrack {LR^{\ast}} \right\rbrack$$$$0 = k_{p}\left\lbrack {LR} \right\rbrack - k_{dp}\left\lbrack {LR^{\ast}} \right\rbrack$$$$\left\lbrack R \right\rbrack_{T} = \left\lbrack R \right\rbrack + \left\lbrack {LR} \right\rbrack + \left\lbrack {LR^{\ast}} \right\rbrack$$

Solving [Equations A47-A50](#equ57 equ58 equ59 equ60){ref-type="disp-formula"}, we obtain the maximum phosphorylated receptor level$$\left\lbrack R \right\rbrack_{T} = \left\lbrack R \right\rbrack + \left\lbrack {LR} \right\rbrack + \left\lbrack LR^{*} \right\rbrack$$

When the ligand concentration is changed from *u*~0~ = \[*L*\]~0~/*K~d~* to *u*~1~ = \[*L*\]~1~*/K~d~* such that \[*L*\]~1~/\[*L*\]~0~ = f, we have (combining [Equations A45 and A51](#equ55 equ61){ref-type="disp-formula"})$$\left\lbrack {LR^{*}} \right\rbrack = \frac{\left\lbrack R \right\rbrack_{T}u_{1}\kappa}{1 + u_{1} + u_{1}\kappa}$$

In [Appendix 1---figure 8](#app1fig8){ref-type="fig"}, we plot the maximum phosphorylation response \[*LR*^\*^\] ([Equation A51](#equ61){ref-type="disp-formula"}) over a range of background concentrations *u~0~* and over multiple folds. We use the parameters obtained for the computational model for EGFR; β = 40 and κ = 20 ([Supplementary file 1](#supp1){ref-type="supplementary-material"}).

![Monomeric receptors exhibit relative sensing.\
The maximum of the phosphorylated receptors level \[*LR*\*\] as a function of background ligand concentration \[*L*\]~0~ for fold changes \[*L*\]~1~/\[*L*\]~0~ in ligand concentration ranging from \[*L*\]~1~/\[*L*\]~0~ = 2 to \[*L*\]~1~/\[*L*\]~0~ = 6.](elife-50342-app1-fig8){#app1fig8}

Section 4.3 Similar to the dimeric case, we next explore how changes in the aggregate parameters *β* and *κ* affect relative sensing for monomer-based receptors signaling. In [Appendix 1---figure 8](#app1fig8){ref-type="fig"}, we show \[*LR*\*\] (scaled) as a function of background ligand concentration at different values of κ and β. As was described in [Appendix 1---figure 5](#app1fig5){ref-type="fig"} for dimeric receptors, different colors represent different accuracy values of relative sensing. For example, the color red represents the range of background ligand concentrations over which the phosphorylation response is within 90% of the maximum (10% deviation). The color yellow represents the range of background ligand concentrations over which phosphorylation response is within 80% of the maximum (20% deviation) and so on. Vertical green lines indicate the region of 90% accuracy; the phosphorylation response \[*LR*\*~2~\] (scaled) varies within 10% of the maximum. The green arrows show the range of background ligand concentrations over which relative sensing holds for the values of *α* and *β* evaluated from the model fits to the data.

[Appendix 1---figure 9](#app1fig9){ref-type="fig"} panel (a) suggests that the relative sensing range is insensitive to changes in κ when β is fixed. At the same time, when *κ* is increased the network exhibits relative sensing at lower ligand concentrations. In [Appendix 1---figure 9](#app1fig9){ref-type="fig"} panel (b), we show \[*LR*\*\] (scaled) as a function of background ligand concentration at different values of β. As β increases, the range of background concentrations over which relative sensing holds increases.

![Dimensionless parameters κ and β dictate the range of relative sensing.\
(**a**) Scaled response \[*LR*\*\] as a function of *u*~0~ = \[*L*\]~0~/*K*~d~ for different values of κ and fold change \[*L*\]~1~/\[*L*\]~0~ = 2 when *β* was fixed at *β* = 40. The colors represent scaled phosphorylation response. The green lines sketch the range of concentrations \[*L*\]~0~ where \[*LR*\*\] is insensitive to the initial ligand concentration \[*L*\]~0~. (**b**) Scaled \[*LR*\*\] as a function of \[*L*\]~0~ for different values of β and fold change \[*L*\]~1~/\[*L*\]~0~ = 2 when *κ* was fixed at *κ* = 20. The green lines sketch the range of concentrations \[*L*\]~0~ where \[*LR*\*\] is insensitive to the initial ligand concentration \[*L*\]~0~. The green arrows show the range of background ligand concentrations over which relative sensing holds for the values of *κ* and *β* estimated based on the model fits to the data.](elife-50342-app1-fig9){#app1fig9}
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Accuracy and robustness of biological signaling is an important concept in systems biology that has received significant attention over the years. In this manuscript, the authors present a novel receptor-based mechanism that is sufficient for cells to compute relative changes of growth-factor concentrations in the extracellular milieu (providing approximate fold change detection or FCD). Experimentally, the authors observe increasing pAKT signaling responses that is concomitant with depletion of surface-exposed EGF receptors in cells exposed to increasing concentrations of EGF. Using ODEs coupled with an elegant analytical model and validation experiments, the authors show that surface receptor downregulation is not only a desensitization mechanism, but also a molecular "reference point" as part of a mechanism that compares background concentrations with future stimuli. Receptor-level relative-sensing imbues cells with a sort of molecular memory that can be used to overcome noisy biological conditions independent of transcription.

**Decision letter after peer review:**

Thank you for submitting your article \"Receptor-based mechanism of relative sensing and cell memory in mammalian signaling networks\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Naama Barkai as the Senior Editor. The following individuals involved in review of your submission have agreed to reveal their identity: Robin E.C. Lee (Reviewer \#3).

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

Accuracy and robustness of biological signaling is an important concept in systems biology that has received significant attention over the years. In this manuscript, the authors present a novel receptor-based mechanism that is sufficient for cells to compute relative changes of growth-factor concentrations in the extracellular milieu (fold change detection of FCD). Experimentally, the authors observe increasing pAKT signaling responses that is concomitant with depletion of surface-exposed EGF receptors in cells exposed to increasing concentrations of EGF. Using ODEs coupled with an elegant analytical model and validation experiments, the authors show that surface receptor downregulation is not a desensitization mechanism, but a molecular "reference point" as part of a mechanism that compares background concentrations with future stimuli. Receptor-level relative-sensing imbues cells with a sort of molecular memory that can be used to overcome noisy biological conditions independent of transcription.

Overall, the work is comprehensive and highlights an important emergent property that arises through receptor endocytosis, a property that may recur in other molecular pathways. Although there is still room for improvements, a suitably revised manuscript would certainly be of interest to a broad biological readership and should be published at *eLife*.

Essential revisions:

1\) Review of previous literature:

1a) The Introduction should include a detailed (2-3 paragraph) discussion of fold change detection and its known mechanisms. The present model has approximate (not exact) FCD, and this should be noted.

1b) EGF signaling is one of the better studied signal transduction processes, and multiple observation related to its many facets have been made before. In particular, it has been noted that EGF receptor indeed responds to the EGF dose logarithmically (see e.g., a number of studies from Steve Wiley). These studies are not discussed in the current manuscript, which is quite surprising. The interpretation provided by Wiley and others is that this logarithmic relationship is a consequence of receptors having high and low affinity binding sites, so that the binding of the ligand and the ensuing response depend on a mixture of these binding sites occupied. Needless to say, there is ample literature to support these findings and this model.

We note that a logarithmic dose response is *not* equivalent to FCD (since FCD is a dynamic property), and thus the present work is novel for the EDF system.

2\) The analytical modeling is a strong point of this paper, it has a remarkable ability to reproduce experimental findings and explains the range of molecular conditions that support relative sensing. This model should have more page space in the main text. Specifically, the motivation for the analytical modeling can be developed more, the dimensionless parameters α and β can be defined in the main text (they are already summarised indirectly). Figure 7---figure supplement 1 presents important results that can be combined with Figure 4 and discussed in accompanying text.

3\) All three reviewers suggested additional experiments as described below. I suggest that the authors add any data they have or can produce in under two months. For experiment where this is not available/possible, I suggest deferring the experiments to future work.

Basically, there is an analysis of wild type cells and an ODE model. The experimental analysis lacks any perturbations to the pathway to really test the ODE model in any particular way. The model analysis lacks distillation to any particular core component or network motif that could be interpreted in a more general manner. One possible experiment to do is overexpression of EGFR, which should keep the cells more sensitive to changes in EGF concentration despite pre-exposure to EGF. An inhibition or knock-down of EGFR should have the opposite effect. Perturbations timed with the fold increase in ligand would have a greater impact. Another experiment would be to pre-expose the cells to EGF for 3 hours, replace with EGF-free media, and measure the rate at which the cell\'s EGF sensitivity reverts back to baseline levels. According to the authors\' model, we should expect to see the EGF sensitivity correlate with the rate at which EGFR is translocated to the cell surface minus the rate at which EGFR is internalized and degraded.

Related to the above, there are multiple pharmacological and genetic methods to perturb receptor trafficking, including its severe inhibition. One needs to test the effects of these perturbations in the overall signaling but also on the specific model predictions, and their validation. The activation of receptor itself upstream of Akt can also be directly tested, e.g., by detecting its phosphorylation status. A better idea of what the pre-stimulation with EGF can do to the cells, including altering the synthesis and degradation rates of the molecules involved in the analysis, and cell behavior (migration, morphology, etc.) should be provided.

The authors emphasize that the proposed relative sensing mechanism is non-transcriptional, but do not provide evidence for this claim. Although the models and experiments demonstrate *sufficiency*, they don\'t demonstrate *necessity* of a receptor-only mechanism in the axis of EGF/HGF-pAKT-FoxO3 signaling. Note that the timescales mentioned in the Introduction overlap with transcriptional timescales (for example, cytokine-induced transcription can be rapid with strong expression that peaks within 30 minutes -- see IL-6 response in PMID: 16191192). I have 2 constructive suggestions: The first would demonstrate necessity by adding additional inhibitor studies: (i) poisoning transcription/translation to demonstrate relative sensing for pAKT/FoxO3 is unaltered; and (ii) inhibiting receptor internalization (MDC, dynasore, etc...) and demonstrating predictable loss of relative sensing (using the model to make predictions). The second suggestion is that the authors can dilute the "non-transcriptional" claims and acknowledge through discussion that transcriptional mechanisms may still supplement the observed non-transcriptional receptor-based mechanism (and explain how future experiments can rule them out).

10.7554/eLife.50342.sa2

Author response

> Essential revisions:
>
> 1\) Review of previous literature:
>
> 1a) The Introduction should include a detailed (2-3 paragraph) discussion of fold change detection and its known mechanisms. The present model has approximate (not exact) FCD, and this should be noted.

We have substantially extended our discussion describing previous studies of fold change detection; we made the corresponding changes in the Introduction (paragraph two) and the Discussion section (paragraphs one and two). We have also clarified that our results represent approximate FCD (Results paragraph seven). Notably, we now also show that, in addition to the maximum pAkt response and the integral of pAkt response, the entire time course of pAkt response depends approximately on the fold change of EGF stimulation and not on the absolute EGF levels (Results paragraph seven and Figure 3---figure supplement 6).

> 1b) EGF signaling is one of the better studied signal transduction processes, and multiple observation related to its many facets have been made before. In particular, it has been noted that EGF receptor indeed responds to the EGF dose logarithmically (see e.g., a number of studies from Steve Wiley). These studies are not discussed in the current manuscript, which is quite surprising. The interpretation provided by Wiley and others is that this logarithmic relationship is a consequence of receptors having high and low affinity binding sites, so that the binding of the ligand and the ensuing response depend on a mixture of these binding sites occupied. Needless to say, there is ample literature to support these findings and this model.

*We note that a logarithmic dose response is* not *equivalent to FCD (since FCD is a dynamic property), and thus the present work is novel for the EDF system.*

We apologize for possible confusion. We have now included several references to previous studies that specifically investigated the biochemical origins of the logarithmic response (Results paragraph two). Importantly, as confirmed by the editor, the logarithmic response is not equivalent and does not guarantee FCD. Thus, previous studies describing the logarithmic response in the system are interesting, but do not compromise the novelty and importance of our work. We have now further clarified this in the manuscript (Discussion paragraph one).

> 2\) The analytical modeling is a strong point of this paper, it has a remarkable ability to reproduce experimental findings and explains the range of molecular conditions that support relative sensing. This model should have more page space in the main text. Specifically, the motivation for the analytical modeling can be developed more, the dimensionless parameters α and β can be defined in the main text (they are already summarised indirectly). Figure 7---figure supplement 1 presents important results that can be combined with Figure 4 and discussed in accompanying text.

We agree with the reviewer. Following the suggestion, we have now included an entire section in the main text, describing in detail the analytical model. We also include the figure illustrating the sensitivity analysis with respect to the two key parameters of the circuit (Results paragraph nine).

> 3\) All three reviewers suggested additional experiments as described below. I suggest that the authors add any data they have or can produce in under two months. For experiment where this is not available/possible, I suggest deferring the experiments to future work.
>
> Basically, there is an analysis of wild type cells and an ODE model. The experimental analysis lacks any perturbations to the pathway to really test the ODE model in any particular way. The model analysis lacks distillation to any particular core component or network motif that could be interpreted in a more general manner.

We thank the reviewers for these comments. As we discuss in the main text, the FCD mechanism, based on receptor endocytosis and downregulation, can be effectively described by several equations. The processes of receptors downregulation and receptor-depended signaling are shared across multiple signaling circuits. Therefore, our results are likely to be quite general. We defer further analysis of similar circuits and motifs to our future work.

> One possible experiment to do is overexpression of EGFR, which should keep the cells more sensitive to changes in EGF concentration despite pre-exposure to EGF. An inhibition or knock-down of EGFR should have the opposite effect. Perturbations timed with the fold increase in ligand would have a greater impact. Another experiment would be to pre-expose the cells to EGF for 3 hours, replace with EGF-free media, and measure the rate at which the cell\'s EGF sensitivity reverts back to baseline levels. According to the authors\' model, we should expect to see the EGF sensitivity correlate with the rate at which EGFR is translocated to the cell surface minus the rate at which EGFR is internalized and degraded.
>
> Related to the above, there are multiple pharmacological and genetic methods to perturb receptor trafficking, including its severe inhibition. One needs to test the effects of these perturbations in the overall signaling but also on the specific model predictions, and their validation. The activation of receptor itself upstream of Akt can also be directly tested, e.g., by detecting its phosphorylation status. A better idea of what the pre-stimulation with EGF can do to the cells, including altering the synthesis and degradation rates of the molecules involved in the analysis, and cell behavior (migration, morphology, etc.) should be provided.

We thank the reviewer for these interesting suggestions. We note that our primary goal in this manuscript was to characterize the behavior of the wild type circuit. To that end, we experimentally measured several key proteins in cells stimulated with two different physiologically important ligands, and multiple fold changes at various background signaling levels. The experiments demonstrated good agreement with our model. We then complemented the experimental measurements with extensive computational modeling, and estimation of multiple systems parameters. Finally, we also performed many detailed analytical derivations.

We agree that perturbing multiple key processes, such as endocytosis, synthesis, and degradation of receptors as well as abundance of other network components are indeed very interesting experiments. However, performing these experiments and their accurate interpretation requires a substantially longer time frame than the under two-month turnaround time specified by the editors. The main reason for this is that perturbations of such key cellular processes is likely to simultaneously change many other components/parameters of the system, such as the relative rates of degradation of active and inactive receptors, the rates of receptor recycling, and potentially the effective phosphorylation and de-phosphorylation rates of various system components. For example, inhibition of clathrin-dependent endocytosis using small molecules inhibitors, such as *dynasore* or *pitstop2*, will potentially affect multiple system processes through a global reorganization of the plasma membrane and the cytosol (see for example \[1-4\]).

For the wild type network, we relied on many previously measured parameters and their literature estimations, but to properly investigate the effects of endocytosis inhibitors or inhibitors of receptors synthesis we need to measure de novo several key parameters of a perturbed system, or at least validate that these parameters did not substantially change. Experimental measurements of these parameters are long-term projects in themselves, and have been previously published as separate research papers focused on specific parameters, such as receptor degradation and endocytosis rates (see for example, \[5-7\]). Therefore, we defer detailed analyses of perturbed networks to our future work.

Below we present several important additional experiments that we were able to carefully perform in under two months. One, following the reviewers' suggestions, confirms a quantitative relationship between the EGFR and Akt phosphorylation. Another, a direct pharmacological activation of Akt, demonstrates that changes at the receptor levels do not affect the inherent activation ability of Akt. Both of these experimental results are essential for our model, but were previously only assumed and not experimentally validated. We also describe experiments, previously performed in our lab on EGFR inhibition, confirming a fast and direct link between EGFR phosphorylation and activation of Akt.

Quantitative relationship between EGFR and Akt phosphorylation:

As the reviewers suggested, it is important to investigate EGFR phosphorylation status, and establish a quantitative relationship between EGFR and Akt phosphorylation. Using quantitative western blot experiments, we have now measured EGFR phosphorylation levels and Akt phosphorylation levels following stimulation with various dosses of EGF (Results paragraph two and Figure 1---figure supplement 3). These experiments demonstrated that Akt phosphorylation levels are approximately linearly related to EGFR phosphorylation levels at the timescales of fast response to EGF stimulation (\~5-10 minutes). Notably, this linear relationship was one of the essential components of the model, and was previously assumed to be true without experimental validation.

Direct pharmacological activation of Akt:

We also performed pharmacological perturbation of the system with a small molecule that directly activates Akt regardless of the EGF receptor status. This pharmacological perturbation demonstrated that the desensitization of Akt phosphorylation response, an integral component of the FCD mechanism, was not due to changes in the inherent activation ability of Akt, for example, phosphorylation status-dependent degradation of Akt \[8\].

We explored direct Akt activation following stimulation with a compound, SC79 \[9\], which binds to Akt and promotes its activation. Notably, SC79 can activate Akt even in the absence of growth factor stimulation. The direct Akt activation experiments (Results paragraph four and Figure 1---figure supplement 4) demonstrated that while pre-exposure to increasing doses of background EGF desensitizes the pAkt response to further EGF stimulation (decreasing blue bars from left to right in Figure 1---figure supplement 4), SC79 is able to activate Akt to the same extent regardless of the background EGF exposure (similar levels of green bars in Figure 1---figure supplement 4). This confirms another central assumption of our model, i.e. that the desensitization of the circuit does not change the inherent ability of Akt to be activated.

EGFR receptor inhibition:

Previous experiments performed in our lab also validate a direct link between EGF receptor phosphorylation and Akt activation. We previously showed (for the same cell line, MCF10A and the same ligand EGF) that pharmacological inhibition of EGFR phosphorylation, with inhibitors *gefitinib* and *erlotinib*, leads to an almost instantaneous downregulation of EGFR phosphorylation levels (t~1/2~ \~ 10 sec) and a rapid downregulation of Akt phosphorylation levels (t~1/2~ \~ 100 sec) \[10\].

*The authors emphasize that the proposed relative sensing mechanism is non-transcriptional, but do not provide evidence for this claim. Although the models and experiments demonstrate* sufficiency*, they don\'t demonstrate* necessity *of a receptor-only mechanism in the axis of EGF/HGF-pAKT-FoxO3 signaling. Note that the timescales mentioned in the Introduction overlap with transcriptional timescales (for example, cytokine-induced transcription can be rapid with strong expression that peaks within 30 minutes -- see IL-6 response in PMID: 16191192). I have 2 constructive suggestions: The first would demonstrate necessity by adding additional inhibitor studies: (i) poisoning transcription/translation to demonstrate relative sensing for pAKT/FoxO3 is unaltered; and (ii) inhibiting receptor internalization (MDC, dynasore, etc...) and demonstrating predictable loss of relative sensing (using the model to make predictions). The second suggestion is that the authors can dilute the "non-transcriptional" claims and acknowledge through discussion that transcriptional mechanisms may still supplement the observed non-transcriptional receptor-based mechanism (and explain how future experiments can rule them out).*

We thank the reviewer for the comments and apologize for possible confusion. We agree that cytokine-induced transcription can indeed be fast, although the typical transcriptional response downstream of EGF is likely to take several (6-8) hours \[11\]. Most importantly, we want to clarify that while the described mechanism is indeed non-transcriptional on the timescales of fast response to an abrupt EGF stimulation (5-15 minutes), transcription and translation play an essential role in the relative sensing circuit that we describe. Specifically, transcription, translation, and delivery of receptors to the cell surface, are all necessary for attaining a background-dependent steady state levels of the membrane receptors, and thus an accurate FCD following further EGF stimulation. We apologize for this confusion and now clarify this in the paper (Discussion paragraph two). As we discussed above, due to the turnaround time frame specified by the editors, we defer experiments on inhibition of transcription and receptor internalization to our future work.
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